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Chronic rhinosinusitis is characterized by substantially different 
inflammatory profiles, so called endotypes. Traditionally, studies on the association 
of specific bacterial patterns with inflammatory profiles of diseases had been 
dependent on clinical phenotypes and bacterial culture. Since the 1980s, molecular 
biology methods have allowed us to study microbial communities by detecting the 
genetic material of microbes in a given environment. Molecular techniques have 
discovered un-cultivable microbes and identified complex microbial communities. 
The microbiota is much more diverse than previously recognized including those 
found in the upper airways. It is widely believed that microbiota is important for 
maintaining human health. An alteration of microbiota may contribute to the 
inflammatory disorders and thus associated with inflammatory endotypes, further 
differentiating clinical phenotypes. 
The common hallmark of chronic rhinosinusitis pathophysiology is an 
inflammation. A key feature of any microorganism is its ability to activate the host’s 
immune system. Microbiota play a critical role in the induction, training, and 
function of the host’s immune system. Therefore, the study of the pathophysiology 
of chronic rhinosinusitis is necessary to establish the relationship between the 
microbiota and inflammatory patterns. Such investigations may elucidate the path to 
therapeutic approaches in correcting an imbalanced microbiota. 
In the introductory chapters, state of the art is presented. First, a brief 
overview of chronic rhinosinusitis pheno- and endotypes will be given. In the 
following part, the hypothesis of the pathogenesis of chronic rhinosinusitis will be 
presented, and the microorganisms in chronic rhinosinusitis are presented. Lastly, 
the microbial ecology in chronic rhinosinusitis is reviewed. 
The first part of studies in this thesis will focus on the association between 
intra-mucosal microorganisms and inflammatory patterns. In a second part, the 
composition and diversity of sinonasal microbiota on mucosal surface are 
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Chapter 1. Chronic rhinosinusitis: 
From phenotypes to endotypes 
Definition of rhinitis and rhinosinusitis 
Rhinitis and sinusitis are inflammatory diseases of the mucosa of the nasal 
and paranasal cavities. The cardinal symptoms of rhinitis, described by the ARIA 
guidelines, are anterior and posterior rhinorrhea, sneezing, nasal blockage, and/or 
nose itching 1. The combined term “Rhinosinusitis” was invented in 1997 by a Task 
Force of the Rhinology and Paranasal Sinus Committee. Sinusitis rarely occurs in 
the absence of rhinitis, and the nose and sinuses are contiguous structures sharing 
vascular, neuronal, and interconnecting anatomic pathways 2. Moreover, the 
inflammatory mediator profile in the nasal mucosa of patients imitates the profile 
found in sinus mucosa 3. As proposed by the European Position Paper on 
Rhinosinusitis and Nasal Polyps (EPOS) expert committee, rhinosinusitis is defined 
as inflammation of the nose and the paranasal sinuses characterized by two or more 
symptoms, one of which should be either nasal blockage/obstruction or nasal 
discharge (anterior/posterior nasal drip). Other symptoms can be facial 
pain/pressure, reduction or loss of smell, or both 4. Acute rhinosinusitis (ARS) is 
clinically defined as symptoms lasting less than 12 weeks with complete resolution.
Chronic rhinosinusitis (CRS) is defined as symptoms on most days lasting at least 
12 weeks without complete resolution. The prevalence of physician-diagnosed CRS 
ranges from approximately 1% to 9% of the general population 5. In 2011, a large-
scale adult population study showed the prevalence of CRS to be 10.9% in Europe 6. 
CRS is a chronic malady with a considerable economic burden resulting from the 
costs of diagnostic tests, medical and surgical therapies, lost and reduced school and 
work productivity, and detrimental impacts on physical and emotional health. 
Classification of chronic rhinosinusitis 
CRS is usually further categorized based on the absence or presence of 
nasal polyps (CRS without nasal polyps, CRSsNP; or CRS with nasal polyps, 
CRSwNP). Although both are characterized by mucopurulent drainage and nasal 
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obstruction, CRSsNP is frequently associated with facial pain/pressure/fullness 
whereas CRSwNP is frequently characterized by hyposmia 7. Based on 
histopathology, CRSsNP is characterized by fibrosis, basement membrane thickening, 
goblet cell hyperplasia, subepithelial edema, and mononuclear cell infiltration, whereas 
CRSwNP is characterized by an intense edematous stroma with albumin deposition, 
formation of pseudocysts, and subepithelial and perivascular inflammatory cell infiltration 
8. Nasal polyps (NP) are believed to arise in the nasal mucosa as a result of chronic
inflammation. NP is defined as pedunculated lesions as opposed to cobblestoned mucosa, 
endoscopically visualised in middle meatus. CRSwNP, a clinical phenotype, is found in up 
to 4% of the population 9. Although, the clinical presentations of CRS are useful in 
treatment planning, clinically defined phenotypes do not provide full insight into the 
potential underlying cellular and molecular mechanisms of CRS 10. CRS is a complex 
disease with several variants caused by different cellular and molecular mechanisms 11. The 
characterization of this heterogeneity supports the concept that CRS consists of multiple 
biological subtypes, or endotypes, which are defined by distinct pathophysiologic 
mechanisms that might be identified by corresponding biomarkers 10. Typically, patterns of 
cytokines for CRSsNP are T helper 1(Th1)-driven, whereas CRS with eosinophilic NP is T 
helper 2(Th2)-biased and CRS with neutrophilic NP expresses increased amounts of 
Interferon gamma (IFNγ) and/or Interleukin (IL)-17 or none of those. Sinonasal tissues 
from cystic fibrosis patients demonstrate high concentrations of IL-17 and IL-8 12. Existing 
evidence suggests an individual inflammatory pattern for patients with CRS. Recently CRS 
has been classified into ten groups based on cluster analysis of biomarkers (Fig 1)13. From 
these 10 biological patterns CRS can be further classified into four endotypes based 
on the pathophysiological and therapeutic principles (Table 1). Those endotypes are 
defined as: (1) Non-inflammatory endotype, (2) Neutrophil endotype, (3) Mainly 
eosinophilic endotype (increased IL-5, ECP, IgE, and albumin) and (4) Cleary 
eosinophilic/SE-IgE endotype (much increased IL-5, IgE, ECP, albumin, and SE-
IgE positive) (Table 2)14. In the whole field of medicine, recognition of endotypes of 
chronic inflammatory diseases is becoming more and more important because it is 
apparent that a traditional management approach of ‘‘one size fits all’’ does not 
adequately treat many patients whose symptoms remain uncontrolled and who have 
severe disease. 
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Figure 1. Simplified graphic showed clusters and their characteristic cytokines, as 
well as the distribution of CRSsNP versus CRSwNP and asthma. For cytokines, white 
indicates no increased concentration, light colors indicate moderately increased 
concentrations, and dark colors indicate strongly increased concentrations. Horizontal lines 
indicate groups of clusters, as determined by IL-5, SE-IgE, and CRSwNP and asthma 
characteristics. ECP stands for Eosinophil cationic protein, MPO for myeloperoxidase. 
(Source: Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic 
rhinosinusitis based on cluster analysis of biomarkers. The Journal of Allergy and Clinical 
Immunology. 2016) 
Table 1. Characteristics of CRS phenotypes and endotypes. 










































Table 2. Endotypes of CRS with clinical findings 
Endotype Clinic 
Non-inflammatory endotype 90% of CRSsNP, 
asthma in <20% 
Neutrophil endotype 70% of CRSsNP, 
asthma in <20% 
Mainly eosinophilic endotype: increased IL-5*, ECP, IgE 
and albumin 
70% of CRSwNP, 
asthma in 20-40% 
Clearly eosinophilic/SE-IgE endotype: much increased 
IL-5**, IgE, ECP, and albumin with SE-IgE positivity 
>90% of CRSwNP, 
asthma in >60% 
*Increased IL-5 means the level of IL-5 between 100 and 200 pg/mL.
**Much increased IL-5 refers to the level of IL-5 above 200 pg/mL. 
(Source: Bachert C, Holtappels G. Pathophysiology of chronic rhinosinusitis, 
pharmaceutical therapy options. GMS Current Topics in Otorhinolaryngology, Head 
and Neck Surgery. 2015) 
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Chapter  2. Pathogenesis of Chronic rhinosinusitis: 
Hypothesis
Chronic rhinosinusitis (CRS) is an umbrella term for a heterogeneous 
group of debilitating chronic inflammatory sinonasal diseases. CRS disease occurs 
at the site of interface between the host and the environment. A number of 
hypotheses have been proposed based on the concept that CRS disease results from 
a dysfunctional interplay between individual host characteristics and factors 
exogenous to the host. 
Etiology of chronic rhinosinusitis 
Universal to the pathophysiology of CRS is the persistence of 
inflammation. A number of hypotheses have been proposed to explain all or part of 
the clinical CRS spectrum 1. However, the cause of this inflammation in an 
individual patient is most often indiscernible. Different immune and inflammatory 
mechanisms are involved in CRS pathogenesis. Historically, CRSsNP was 
considered to be the result of an incompletely treated or unresolved bacterial 
infection, while CRSwNP was regarded as a noninfectious disorder linked to atopy2. 
Research over the last  20 to 30 years has indicated that the etiology and
pathogenesis for both forms are far more complex and overlapping 3. Nowadays, 
CRS disease is described as an umbrella term for a heterogeneous group of 
inflammatory conditions of sinonasal mucosa resulting from the interaction of 
multiple host and environmental factors. Here, we discuss the etiology of CRS as 
environment-related hypothesis (fungal pathway, microbial elements pathway), 
host-related hypothesis (eicosanoid pathway, immune pathway), and microbiota 
dysbiosis pathway. 
Fungal pathway 
Fungi have been considered as causal pathogens in CRS diseases by 
researchers from the Mayo Clinic 4. Evidence of fungi, eosinophilic mucin, and 
eosinophils in the nose and sinuses is present in nearly all patients with CRS. Our 
group published data that fungal hyphae, Charcot Leyden crystals and eosinophilic 
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mucin could be found in 7% of CRS patients and was related to recurrence of 
disease 5. However, multiple studies are unable to detect a significant difference in 
fungal isolation between CRS patients and healthy control subjects 6. Although 
fungal microorganisms were identified in the sinonasal cavities of essentially 100 % 
of both CRS patients and healthy control subjects, CRS cases show an exaggerated 
immune response to fungal antigens 7. At present, the fungal hypothesis has been 
largely dismissed for multiple reasons. The most important reason is that treatment 
of CRS patients with antifungal agents did not show any evidence of efficacy in 
modifying the CRS disease process 8. Currently, fungi are no longer viewed as the 
principal cause in CRS context. Fungi, bacteria and virus probably contribute to 
some extend to CRS disease under certain circumstances. 
Microbial elements pathway 
Early research on CRS pathophysiology was mainly considered on the 
basis of infection model of disease, with a focus on identifying a pathogenic 
microbial driver for the inflammatory response. Suggestions of a viral cause of CRS 
have largely been disappointing because of the lack of convincing evidence for such 
a cause 9-11. Prevailing evidence indicated bacteria to be a promising infectious agent 
that caused CRS. Previous culture-based studies counted Staphylococcus aureus, 
Haemophilus influenzae, and Pseudomonas aeruginosa as potential pathogens. 
Since the discovery of IgE antibodies to S. aureus enterotoxins A and B in nasal 
polyp tissue homogenates 12, much of further research in the pathogenesis of CRS 
has focused on the possible role of S. aureus and its products. S. aureus colonization 
rates have been higher in CRSwNP patients than those of healthy control subjects 
and CRSsNP patients 13. Furthermore immunoglobulin E specific to staphylococcal 
enterotoxins (SE-IgE) has been detected in polyp homogenates, but not in control or 
CRSsNP tissues 12. The level of SE-IgE in the sinonasal tissue is associated with 
high total IgE titers 12. This IgE antibody appears to be functional and may induce 
mast cell degranulation to numerous inhalant allergens 14. Moreover Staphylococcus 
enterotoxins (SEs) are regarded as superantigens. SEs, produced by the S. aureus, 
amplifies the local eosinophilic response 12. SEs may serve as an allergen and may 
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contribute to persistent inflammation by continuously activating mast cells. SEs 
significantly down regulates prostaglandin E2, cyclooxygenase 2, and prostaglandin 
EP2-receptor mRNA expression, pointing to an effect of staphylococcal 
superantigen on eicosanoid metabolism in the upper airway tissue 15. Bachert and 
colleagues have reviewed the role of staphylococcal superantigen in the upper 
airway 16-18. Other virulence factors would be e.g. serine protease-like proteins 
(Spls), inducing a Th2-biased inflammatory response in the airways via an IL-33-
dependent manner 19,20. Current evidence indicates that S. aureus and its secreted 
proteins are disease modifiers for the development of nasal polyposis, rather than etiologic 
agents 16. There is only a little evidence so far that S. aureus can cause disease in the 
human in an otherwise disease-free airway. Other microbes also may play a part in 
the pathomechanism of CRS. Today, it is generally accepted that the “singular cause 
vision” is an inadequate approach to explain the pathophysiology of CRS. 
Eicosanoid pathway 
Eicosanoids are signaling lipids that regulate pivotal homeostatic functions 
such as inflammation, immunity, and messenger networks in the central nervous 
system 21. Their synthesis starts when the cell, activated by mechanical trauma, 
cytokines, pathogens or other stimuli, triggers the release of membrane-bound fatty 
acids that are then metabolized via the cyclooxygenase and/or the lipoxygenase 
pathways. Alterations in the arachidonic acid pathway, leading to an imbalanced 
production of eicosanoids, have been linked to the pathophysiology of CRSwNP 
diseases, asthma, and aspirin-exacerbated respiratory disease 22. This imbalance is 
characterized by increased synthesis of pro-inflammatory mediators such as 
cysteinyl leukotrienes by inflamed tissue in addition to decreased anti-inflammatory 
molecules such as prostaglandin E2 release when compared with normal tissue, 
correlating with the inflammatory pattern and severity of the diseases 22. 
Furthermore, anti-leukotriene agents improved subjective and objective symptoms 
of CRSwNP patients, especially patients with comorbid asthma 23,24. Leukotriene 
inhibitors reduced nasal polyp size and decreased recurrence rate of nasal polyp 
30 
after surgery 25. These evidences suggest that eicosanoids could contribute to the 
pathophysiology of CRS. 
Immune dysfunction pathway 
Due to a failure of defining microbial agents, e.g. fungi and S. aureus, as 
the primary cause of CRS, the immune dysfunction hypothesis was proposed to 
fulfill the pathomechanism of CRS. The possible mechanisms are deficiency of 
innate immune response, and aberrant communication and/or signaling between the 
innate and adaptive immune responses. With regard to the tissue level, macrophages 
in NP tissues showed decreased engulfment of S. aureus 26. Furthermore, nasal 
tissues from CRSwNP patients showed a significant deficit in IFN-γ response to 
viral infection 27. These defects may increase pathogen access and result in an 
aberrant immune response. Peripheral blood leukocytes isolated from CRS patients 
produce IL-5 when challenged by common microbial agents 28. Moreover, there is a 
meta-analysis study that reveals an immunoglobulin deficiency in CRS patients 29. 
Approximately one in four patients with difficult-to-treat CRS had IgG, IgA, and 
IgM deficiencies 29. These findings indicate an abnormal immune system in CRS 
patients, although we cannot proof if this aberrant immune system is a cause or a 
consequence of inflammation. Additional studies on the immune system in CRS 
patients are necessary to make a conclusion. 
Microbiota dysbiosis pathway 
There is a general consensus that the microbiota have implications in 
human health and disease 30. The role of microbiota in shaping the immune response 
has been largely recognized. Stable microbiota contribute to fortification of the 
epithelial barrier and development of innate and adaptive immune properties 31. This 
hypothesis proposes that changes in host-microbiota relationship (dysbiosis) can 
result in an aberrant immune response leading to chronic inflammation. Two 
possible mechanisms into the pathogenesis of CRS are (1) colonization resistance, 
and (2) tonic activation of immune response. The microbiota dysbiosis hypothesis 
incorporates host and environmental factors. It is the broadest and most inclusive 
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hypothesis for CRS etiology and pathogenesis. This hypothesis can account for, 
rather than conflict with, the most prominent data supporting the other postulations. 
Studies about the impact of sinonasal microbiota in the pathogenesis of CRS are 
beginning to emerge. Prevailing studies report that the characteristics of sinus 
microbiota in CRS cases were similar to those of healthy control subjects 28,32,33 
whereas other analyses, making use of CRS phenotypes or endotypes, demonstrated 
different compositions of resident bacterial communities 34-36. The amount of 
evidence is still relatively scant; hence, sinonasal microbiota will require more extensive 
studies to address the role of microbiota dysbiosis in the pathogenesis of CRS. 
Conclusions 
There are many different hypotheses related to CRS etiology. Fungi and 
bacteria have been implicated as important environmental factors contributing to 
chronic mucosal inflammation and have formed the basis for discussion of the 
fungal pathway and microbial elements pathway. In contrast, the eicosanoid 
pathway and the immune dysfunction pathway highlight the contribution of host 
variables. Host and environmental factors are entwined by the microbiota dysbiosis 
pathway (Fig 1). There is strong evidence supporting an important role for both host 
and environmental factors in CRS pathophysiology. We have an incomplete 
understanding of the molecular pathways that lead to the tissue manifestations and 
clinical symptomatology defining CRS. Therefore, identification of specific disease 
subgroups within the broad concept of CRS, linked to etiology is an important and 
challenging task in future research. 
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Figure 1 The etiologic factors of CRS disease. 
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Chapter 3. Microorganisms in Chronic rhinosinusitis 
An infectious etiology for CRS has long been postulated 1. There is 
significant scientific evidence that acute rhinosinusitis (ARS) is primarily an 
episodic viral infection of the paranasal sinuses. However, current evidence is 
relatively scant for supporting viruses as a significant component in the 
pathogenesis of CRS. According to studies using PCR techniques, there was no 
significant difference in the rate of viral infections between healthy control subjects 
and CRS cases 2. Furthermore, viral elements have not been detected in sinonasal 
tissues of CRS patients 3. The most important progression of acute rhinosinusitis is 
superinfection of bacteria on mucosa damaged by viral infection. The most common 
pathogens associated with bacterial acute rhinosinusitis are Streptococcus 
pneumoniae and Haemophilus influenzae 4. The transition of bacteria from acute to 
chronic status has been evaluated by repeated endoscopic sinus aspirations 5. 
Initially, S. pneumoniae, H. influenzae and Moraxella catarrhalis were recovered. 
Failure to respond to therapy was associated with the appearance of resistant 
bacteria in subsequent aspirates. These included Fusobacterium nucleatum and 
species of the genera Prevotella, Porphyromonas and Peptostreptococcus. Based on 
conventional culture techniques, there are significant differences in the 
microbiology of CRS as compared with ARS 6. Staphylococcus aureus, 
Staphylococcus epidermidis, and anaerobic Gram- negative bacteria predominate in 
CRS patients. Recovery of Gram-negative rods, including Pseudomonas 
aeruginosa, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter spp., and 
Escherichia coli, were also reported 7. These bacteria are rarely recovered from 
middle meatus cultures obtained from healthy individuals. Their isolation from 
symptomatic patients suggests their pathogenic role 8. These data provide evidence 
that bacteriology in CRS patients is different from that of healthy control subjects 
before acquisition of CRS disease. It is fair to say that bacteria are encountered 
frequently in the setting of CRS; the microbial community of the paranasal sinuses 
seems to be altered. This bacterial community is often polymicrobial and may 
exhibit significant antibiotic resistance. 
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We reported for the first time that an increased rate of S. aureus 
colonization in middle meatus nasal swabs from CRSwNP patients (63.7%) was 
higher than those of CRSsNP patients (27.3%). Even higher rates were detected in 
CRSwNP patients with asthma (66.7%) and aspirin hypersensitivity (87.5%), 
whereas the S. aureus colonization rate between CRSsNP patients and healthy 
control subjects did not reach a statistically significant difference 9. This evidence 
highlighted the role of S. aureus in pathogenesis of CRS disease. The colonization 
rates of S. aureus in CRSwNP patients are positively correlated with S. aureus 
enterotoxin-specific IgE (SE-IgE) in nasal tissue homogenates; however, S. aureus 
colonization rates always exceeded the SE-IgE rates. The presence of SE-IgE in 
nasal polyps is strongly associated with co-morbid asthma. In a subgroup of 
CRSwNP patients, S. aureus seemed to enhance type 2 inflammation. S. aureus may 
initiate and maintain chronic inflammation via its various secreted proteins, 
although various other microbes may play a role either in the progression or the 
termination and prevention of sinus disease. 
Most microbes cannot be cultured in the laboratory. It is estimated that 
culture-dependent methods demonstrate only 1% of microorganisms in nature 10. 
Since the application of molecular methods, DNA-based techniques have been 
developed allowing researchers to identify bacteria in sample material without 
cultivation 11. The study of the genetic material of microorganisms in a particular 
environment, termed microbiota, is one of the new perspectives in human health 
research 12, including CRS. An emerging body of evidence in the field of human 
microbial ecology is redefining our perception of the human superorganism and the 
delicate balance between the host immune response and the microbial populations 
13. The Human Microbiome is the collection of all the microorganisms living in
association with the human body. The traditional hypothesis was that humans live 
with ten times more bacterial cells than human cells 14, however, more recent 
estimates have lowered that to 3:1 and even to approximately the same number 15. 
These microbes are generally not harmful to human, in fact they are essential for 
maintaining health. Microbiologists point out that if all of a person’s DNA were 
mixed with the body’s entire bacterial DNA, that person would be genetically more 
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bacterial than human. Bacterial gene content is more than 100 times that of the 
human genome 16. Cooperative interactions between microbes and their hosts typically 
involve microbial participation in host functions such as defense, metabolism, and 
reproduction. For example, they produce some vitamins, break down our food to extract 
nutrients we need to survive, teach our immune systems how to recognize dangerous 
invaders and even produce helpful anti-inflammatory compounds that fight off other 
disease-causing microbes. 
Many microorganisms colonize humans. Populations of microbes inhabit 
the skin and mucosal surfaces in various parts of the body 17. Traditional 
microbiology has focused on the study of individual species as isolated units. 
Historically, research on pathogenesis of the condition neglected the roles of 
resident microbial communities (where most pathogens function). Indeed, many 
researchers eliminate the native microbial communities of their model hosts to 
simplify analysis of pathogens that infect them. Because interest in the involvement 
of those communities in host health centers largely on how they modulate host 
defenses. More efforts are needed to address the purely microbial interactions that 
influence how pathogens affect those microbial communities as they also colonize 
their hosts. It is clear that chronic inflammatory diseases represent a significantly 
more complex interaction between microbial communities and host inflammatory 
response than was previously understood. Studies of a variety of microorganisms 
including eukaryotes (fungus), archaea, bacteria and viruses should pave the way for 
more understanding of how the host microbiome contributes to pathogenesis. In the 
context of CRS, roles of bacteria in the pathogenesis are currently being reassessed. 
Modest improvement in some patients with CRS can occur with antibiotic therapy 
18. So far there is no convincing evidence to support viruses as a cause of CRS 2,3,19.
The potential roles of fungi are questioned by the failure of antifungal therapeutics 
to improve CRS symptoms 20. 
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The role of the microbiota in regulation of epithelial and airway 
inflammation has seen a recent explosion in promising research. Many investigators 
have reported that the quality of sinus microbiota in CRS is similar to that of control 
groups, but several studies indicate that alterations in the airway microbiota can be 
associated with inflammatory processes. The nasal microbiota appear to have 
potentially promising roles in many aspects of sinus health and disease. The 
research into the consequences of sinus dysbiosis can thus be used to explore and 
further define mechanisms of disease. The study with well-defined subgroups will 
be able to clearly demonstrate different pathologic or immunologic characteristics. 
Exploration of the relationships between microbes and their impact on the sinonasal 
immune responses may lead to a greater understanding of the pathogenesis of CRS 
and thus result in new strategies for its treatment. 
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Parts of this chapter were published in Chalermwatanachai T, Velasquez LC, Bachert C. 
The microbiome of the upper airways: focus on chronic rhinosinusitis. 
The World Allergy Organization Journal. 2015;8(1):3. 
Chronic rhinosinusitis (CRS) is a persisting inflammatory condition of 
nasal and paranasal cavities. Microorganisms are believed to be important 
contributors to the inflammatory response seen in these patients. Traditionally, 
studies on the association of bacterial community and CRS disease depended on 
bacterial culturing techniques. The advent of molecular biology methods has 
allowed us to study microbial communities and demonstrated that the human being 
inhabited by abundant and diverse bacteria that cannot be detected by culture-based 
methods. Molecular techniques have identified complex microbial communities. 
Parallelling groundbreaking research in the gastrointestinal tract suggests that the 
gut microbiota may contribute to chronic inflammatory disorders such as 
inflammatory bowel disease and atopy. Following this perspective, it is likely that 
the respiratory microbiota may also have an impact on development and severity of 
airway inflammation. 
Techniques in microbial community studies 
Historically, Gram stain and microscopy identify in situ the members of a 
microbial community. The staining properties and morphology methods could 
distinguish many broad clades of bacteria but were non-specific at lower taxonomic 
levels. Nowadays, there are two principal approaches to analyze the microbial 
community in a given environment: culture-dependent and culture-independent 
techniques. 
Culture-dependent methods involve isolation and culturing of 
microorganisms prior to their identification according to morphological, 
biochemical or genetic characteristics. These methods are time-consuming, and 
biased, as certain media and growth conditions favor the growth of some bacteria 
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over others. In addition, this approach may not provide a true reflection of the 
diversity of microbes in a sample. A “no growth” result does not necessarily imply 
that a sample is sterile. It is estimated that up to 99% of microorganisms observable 
in nature typically are not cultivated using standard techniques 1. Un-cultivability is 
a wide-spread condition that includes: (i) organisms for which the specific growth 
requirements (nutritional, temperature, aeration, etc.) are not fulfilled; (ii) slow-
growing organisms, out-competed in the presence of fast-growing microorganisms 
and (iii) disfavored organisms, which cannot stand the stressful conditions imposed 
by cultivation 1. This approach camouflages the true bacterial community in a 
sample. Thus, there needed to be a better approach to analyze these microorganisms. 
Since the 1980s, the application of molecular detection methods has allowed culture-
independent investigations of the microbial communities 2. Culture-independent methods 
explore microorganisms in a sample by detecting the basic unit of life, nucleic acids. The 
earliest DNA-based methods examine the community by hybriding genes of interest (i.e., 
fluorescence in situ hybridization: FISH and Microarray) or amplifing specifically-targeted 
genes (such as denaturing/temperature gradient gel electrophoresis: DGGE/TGGE, restriction 
fragment length polymorphisms: RFLP). Table 1 summarizes molecular methods of 
microbial detection. Molecular techniques have proven effective in characterizing complex 
microbial assemblages in environmental samples 3; however, an important caveat of 
molecular techniques is the ability to detect the genetic material of non-viable 
microorganisms. Fundamentally, a microbial community consists of a collection of individual 
microbe cells, each carrying a distinct complement of genomic DNA. As a full sequence of 
every genome in every cell is impractical, microbial ecology has defined a number of genes 
or other DNA sequences that can assign microbes to a particular taxon. There are different 
DNA sequences, which can be chosen for analyzing different populations including 
ribosomal protein subunits, elongation factors, and RNA polymerase subunits. Of those, the 
16S ribosomal RNA (16s rRNA) gene is widely applied for exploration of bacterial diversity 
in the environment because of (i) its presence in all bacteria, often existing as a multigene 
family, or operons; (ii) the stability of the 16S rRNA gene, suggesting that random sequence 
changes are a measure of time (evolution) rather than a reflection of different microbiota; and 
(iii) the size of 16S rRNA genes (1,500 bp) being large enough for informatics purposes 3. 
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Table 1. Molecular methods of microbial detection 
Technique Description 
FISH DNA probe Fluorescently labeled specific oligonucleotide probes are 
hybridized to a microbial community for marker genes. 
Microarrays Fluorescently labeled nucleic acids are hybridized to 
organism-specific oligonucleotides placed onto silicon 
plates and visualized by using fluorometry. 
PhyloChip The PhyloChip assay is a microarray-based method that 
identifies and measures the relative abundance of microbial 
taxa. This approach relies on the analysis of the 16S 
ribosomal RNA gene sequence. 
Ibis T5000 biosensor  A nucleic acid with a target sequence is amplified by PCR 
then products are injected to high-performance electrospray 
ionization mass spectrometry and base-composition 
analysis. 
DGGE/TGGE DNA fragments from a sample are amplified by PCR; 
products are then subject to gel electrophoresis and 
increasing either concentration of denaturing reagents or 
temperature; unique dsDNA fragments will then migrate 
and melt at different positions along the gel. 
RFLP DNA sample is digested by restriction enzymes and the 
resulting restriction fragments are separated according to 
their lengths by gel electrophoresis. 
Quantitative PCR Primers and fluorescent labels are used to quantify the 
abundance of select DNA templates. 
Sequencing Genes of conserved loci with hypervariable regions (i.e., 
16S rRNA) are amplified, sequenced, and compared with 
databanks of known gene sequences for taxa identification. 
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Moreover, there are several available databases of 16S rRNA gene with 
reference sequences and taxonomies such as Greengenes 4, SILVA 5 and the 
Ribosomal database project 6. 
The introduction of next generation sequencing (NGS) in 2005 7 changed 
the history of genomic research as it increased sequencing throughput (Second-
generation DNA sequencing), and did not require prior cloning steps (Third-
generation DNA sequencing) 8. NGS can be used to sequence every nucleotide in an 
individual’s DNA, or can be limited to smaller portions of the genome. Second-
generation DNA sequencing platforms are commercially available allowing us to 
sequence DNA much more quickly and cheaply. Third-generation DNA sequencing 
uses single DNA molecules rather than amplified DNA as a template. Thus, third-
generation DNA sequencing potentially eliminates errors in DNA sequence 
introduced in the laboratory during the DNA amplification process. NGS 
technologies are not only changing our genome sequencing approaches, but also 
developing many exciting fields such as metagenomics, meta-transcriptomics and 
single-cell genomics. Metagenomics is defined as the direct genetic analysis of 
genomes contained with an environmental sample and produces a taxonomical 
profile of the sample. An advent of metagenomic analysis coined the term 
“microbiota” and “microbiome” for microbial community study. Microbiota is 
defined as the microbial taxa that are associated with an environment and are 
revealed by using molecular techniques i.e. 16S rRNA gene sequencing. 
Microbiome refers to microbiota and their genes as well as their products in a given 
milieu 9. Furthermore, some researchers add the host and environmental factors in 
the term microbiome. Meta-transcriptomics is the sequencing of the transcriptome 
(mRNA) that permits us to evaluate the gene expression of the microbial 
community. Deep sequencing of DNA and RNA from a single cell, single-cell 
genomics, let us extensively investigate the cellular functions. Currently, almost all 
microbial ecology studies employ high-throughput DNA sequencing to explore 
microbial communities and combine with other platforms such as proteomics or 
metabolomics to investigate a functional part of microbial communities. 
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At presence, researchers have a large choice in formulating methodological 
strategies: depending on the access to the technology, budget, and objectives of research. 
Each culture-independent methodology has its own limitations and biases. Investigators 
must take additional measures for example one may use more than one molecular 
technique or a culture-dependent approach in parallel to provide additional validation of 
results and reduce the possibility of false findings due to methodological errors and biases. 
Although the culture-independent techniques have the ability to detect more microbes than 
culture technique, the culture-dependent methods so far remain a better means of obtaining 
individual isolates contributing and obtaining isolates for further assays. 
The sinonasal microbiota in chronic rhinosinusitis 
As the gate into our body, the respiratory tract itself harbors a 
heterogeneous microbiome that decreases in biomass from upper to lower tract 10. 
The sinonasal cavity, the anatomical region responsible for initially filtering the 
inspired air, is heavily colonized by microbes. The development of culture-
independent molecular techniques allows the detection of more bacteria and reveals 
greater biodiversity than conventional culture 11,12. Thus, the etiology of CRS may 
be polymicrobial and the role of anaerobe bacteria may be more prominent than 
presumed. The culture-independent molecular techniques are enhancing our ability 
to understand the bacterial community in pathologic condition. However, it is likely 
that the bacteria detected by culture-dependent techniques still are of clinical 
relevance to identify specific pathogens in order to direct antibiotic therapies and 
eradicate bacteria13. 
An important step for a meaningful evaluation of the sinonasal microbiota 
is to obtain a suitable biological sample. Specimen collection is one of the most 
important steps in the analysis of areas that are difficult to access, such as the 
sinuses. It must not be biased by interference from the nares. Specimen can be 
tissue, nasal secretions, or material sampled by a swab. Researchers have 
investigated the suitable specimens for microbiota studies in CRS. They found that 
there is no significant difference between simple swabs and mucosa tissue samples 
as sampling techniques 14,15. The use of an endoscope for the sampling is 
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recommended, although simple swabs are often used in both healthy subjects and 
diseased patients. Samples can be collected from various anatomical locations in the 
nose such as the inferior turbinate, the middle-meatus, the ethmoidal sinuses, the 
sphenoid, and the anterior nasal cavity. A study of variation in the microbial 
community of the intra-nasal site revealed a variation in microbial community 
according to site epithelium type in the sinonasal environment 16. There is a 
difference in community composition between squamous epithelium (i.e., anterior 
nares) and ciliated pseudostratified columnar epithelium (i.e., middle meatus, and 
sphenoethmoidal recess). The middle meatus, delineated/bordered by the middle 
turbinate and lateral nasal wall, receives drainage from the maxillary, anterior 
ethmoid, and frontal sinuses. The sphenoethmoidal recess is located in the posterior-
most aspect of the nasal cavity, between the nasal septum and superior turbinate that 
receives drainage from the posterior ethmoid and sphenoid sinuses.Microbial 
composition at middle meatus and sphenoethmoidal recess is nearly identical (Fig 1)16. 
This indicates that collecting middle meatus swabs is an appropriate sampling 
technique for DNA-based bacterial assays of paranasal sinuses. This statement is 
also supported by cultivation-based studies. The microbiology of the middle meatus 
correlates well with a pathogenic organism of CRS disease 17, whereas swabs of the 
nares would not be appropriate as a replacement of middle meatus swabs in 
investigations of CRS pathogens. Researchers can use appropriate protective devices 
such as a sterilized Killian nasal speculum with long leaves to avoid contamination 
by the nasal vestibule microbes. 
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Figure 1. The scheme indicates epithelium type, bacterial communities and 
locations of the anterior naris, middle meatus, and spenoethmoidal recess in the 
human nasal cavity. 
(Adapted from Yan M, Pamp SJ, Fukuyama J, et al. Nasal microenvironments and 
interspecific interactions influence nasal microbiota complexity and S. aureus 
carriage. Cell Host & Microbe. 2013) 
54 
The traditional view that the paranasal sinuses were an aseptic condition in 
a healthy person has been largely abandoned. The presence of viable bacteria in 
healthy sinuses is now well-documented 18. Early studies using culture-based 
techniques have now been replaced in the research setting with detection and 
identification of microbes using nucleic acid-based methods, which appear to be less 
biased and more sensitive than traditional culture. Before the era of culture-
independent methods, conventional cultures have implicated Staphylococcus aureus, 
and Pseudomonas aeruginosa as principal pathogens in CRS disease 19. At the start of 
the molecular era, researchers employed culture-independent methods to characterize 
the bacterial communities in CRS patient. Molecular techniques were more sensitive 
than culture techniques, however, they did not identify the novel organisms 
implicated in the etiology of CRS context 11,12. There is no current consensus on the 
most common bacteria present in the healthy or diseased state. There is no clear 
‘causative’ or ‘protective’ single organism. However, some commonalities have 
been identified in multiple studies. The sinus microbiota of CRS patients exhibit 
significantly reduced bacterial diversity compared to those of healthy control 
subjects. Propionibacterium acnes, S. epidermidis, S. aureus and Corynebacterium 
spp. have been frequently identified as prevalent and abundant species in sinonasal 
microbiota. Furthermore, a number of particular species commonly viewed as being 
pathogenic, including anaerobic microbes, P. aeruginosa and Haemophilus spp., 
have been observed in both healthy and CRS subjects. Table 2 provides the studies 
that using high throughput sequencing of the bacterial 16S rRNA gene for the 
identification of microbiota in CRS context. 
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Summary and perspective of nasal microbiota studies 
Prior airway microbiota studies revealed several critical factors. It is likely 
on an account of the substantial technical variation in the methodological 
approaches employed by different studies. Differences in a patient population, 
sampling sites and techniques, target gene regions, sequencing platforms, 
bioinformatics pipelines, and taxonomic assignment databases may have an impact 
on microbial evaluation; however, a few patterns do emerge. Actinobacteria (i.e., 
Corynebacterium spp. and Propionibacterium spp.) have been identified as 
prevalent and abundant microbes in healthy control subjects. CRS patients often 
have lower bacterial diversity than that in healthy control subjects. S. aureus is 
detected to be significantly more prevalent and abundant in the CRS groups versus 
control groups. Although the composition of the microbiota in healthy control 
subjects and CRS patients is increasingly well-described, the role of the microbiota 
in the pathogenesis of CRS disease remains unclear. A study with well-defined 
patients, using phenotypes and potentially endotypes of CRS disease can possibly 
identify signature microbiota, which might be related to specific pathological or 
immunological characteristics of the inflammation. Research on how microbiota 
impact on the immune response of nasal and sinus mucosa may shed a new light on 
the pathophysiology of CRS disease and consequently may result in new strategies 
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Chapter 5. Aims of the study 
The etiology of chronic rhinosinusitis (CRS) remains only partially 
understood. CRS is a heterogeneous condition characterized broadly by persistent 
inflammation of the sinonasal mucosa. The causes of inflammation in CRS are 
diverse and multifactorial, relating to overlapping host and environmental triggers. 
Microorganisms (i.e., bacteria, and fungi) have long been considered as an 
inflammatory initiator, or at least contribute to its persistence. Modern culture-
independent techniques have vastly improved our understanding of the complex 
microbial communities associated with the human body. It has been suggested that 
CRS occurs as the result of an inappropriate or exaggerated response to external 
environmental triggers. Therefore, local environmental factors e.g. resident 
microbes may contribute to the pathogenesis of CRS. 
Aims of this thesis 
The aim of the work described in this thesis was to determine the possible 
interaction between microbiota and the mucosal immune reaction, and thus on the 
development of inflammation in chronic rhinosinusitis. The study aims:  
1) To investigate the association between mucosal microorganisms and
inflammatory patterns, using peptide nucleic acid fluorescence in situ hybridization 
(PNA-FISH). 
2) To compare the composition and diversity of the nasal microbiota of healthy
controls to the composition and diversity of the nasal microbiota of patients with 
CRSwNP, employing high throughput sequencing of the bacterial 16S rRNA gene. 
After identifying the microorganisms, we attempted to investigate the role they play 
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Chapter 6. Association of Mucosal Organisms with 
Patterns of Inflammation in Chronic Rhinosinusitis 
Based on: Chalermwatanachai T, Zhang N, Holtappels G, Bachert C. 
Association of mucosal organisms with patterns of inflammation in chronic rhinosinusitis. 
PloS One. 2015;10(8):e0136068. 
Introduction 
Chronic rhinosinusitis (CRS) can be classified into two clinical subgroups 
(phenotypes) based on the absence and presence of nasal polyps (CRSsNP and 
CRSwNP) 1. These two subgroups may be further divided into several disease 
endotypes based on the cytokine composition predominant within the tissue 2. The 
phenotype is useful in treatment planning while the endotype provides insight in 
pathophysiological mechanisms of CRS. Therefore, investigations of the 
pathogenesis and the factors amplifying mucosal inflammation are of crucial 
importance for the development of new diagnostic and therapeutic tools. 
In our previous findings, using the peptide nucleic acid-fluorescence in situ 
hybridization (PNA-FISH), we reported a higher quantity of Staphylococcus aureus 
in nasal polyps (NPs) tissues from patients with aspirin exacerbated respiratory 
disease 3. We also found an association between gram-positive bacterial colonization 
and interleukin (IL)-5-positive NPs, whereas gram-negative bacteria were associated 
with IL-5-negative NPs 4. Thus, specific inflammatory endotypes are likely to be 
associated with the intramucosal presence of specific bacteria but it remains unclear 
which organisms are related to the different endotypes. 
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Microorganisms have a possible influential role, at least in selected subsets 
or endotypes of CRS; mucosal bacteria might have a specifically direct and strong 
impact on the mucosal immune system. To validate this hypothesis, we attempted to 
illustrate the association of specific microorganisms and specific inflammatory 
patterns. The main emphasis of the current study was on intra-mucosal 
microorganisms such as S. aureus, Pseudomonas aeruginosa and Escherichia coli, 
and fungi, all detectable by the PNA-FISH. 
Materials and Methods 
Patient groups and samples 
Sinonasal tissue samples (n=115) with defined disease and pathology were 
selected from a sinonasal tissue collection at the Department of 
Otorhinolaryngology, Ghent University Hospital. These sinonasal tissues were 
obtained from patients in the academic center who probably had prolonged medical 
treatment. The study for collecting human sinonasal tissue samples was approved by 
the ethics committee of the University of Ghent, Belgium and appointed the number 
B67020111209. All patients gave written informed consents before being operated 
on. These sinonasal tissue samples were obtained from patients during endoscopic 
sinus surgery. The inferior turbinates from patients undergoing septoplasty without 
sinus disease were used as control. The diagnosis of CRS in each patient was in 
compliance with the EPOS guidelines. Diagnosis of cystic fibrosis (CF) and asthma 
was subsequently confirmed by a pediatrician/pulmonologist. The atopic status was 
evaluated using the skin prick tests to common inhalant allergens. Cytokine profiles 
(Box 1) were performed on all disease tissue samples. Sinonasal tissue samples were 
classified into five groups according to their cytokine composition: sinonasal tissues 
from CRSsNP patients with tumor necrosis factor alpha (TNFα) mucosal 
concentrations < 20 pg/ml or > 20 pg/ml, sinonasal tissues from CRSwNP patients 
with IL-5 and SE-IgE expression, sinonasal tissues from CRSwNP patients without 
IL-5 and SE-IgE expression, and sinonasal tissues from patients with CF. 
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Box 1. Cytokine profiles and their function 
Cytokine profile Interpretation of increased concentrations 
TNFα Proinflammatory action 
IFNγ Th1 activity 
IL-5 Th2 activity 
SE-IgE Marker for superantigen effect on local mucosa 
IgE Adaptive immunity marker 
ECP Eosinophilic activity marker 
IL-22 Th22 activity 
IL-17A Th17 activity 
Measurement of Cytokines in Tissue 
Snap-frozen tissue specimens were weighed and suspended in a ratio 0.1 g 
of tissue per 1 mL of 0.9% NaCl solution with a complete protease inhibitor cocktail 
(Roche; Mannheim, Germany). To prepare soluble protein fractions, the frozen 
tissues were pulverized using mechanical Tissue Lyser LT (Qiagen Hilden, 
Germany) at 50 oscillations per second for two minutes in prechilled Eppendorf 
tubes. Homogenized tissues were centrifuged at 1,800x g for five minutes at 4°C, 
and the supernatants were collected. Total IgE, eosinophil cationic protein (ECP) 
and specific IgE to staphylococcal enterotoxins (SE-IgE) were measured using the 
UniCAP system (Phadia; Uppsala, Sweden). Assay of the TNFα, interleukin (IL)-5, 
and IL-17 were performed using Luminex (R&D system; Minneapolis, MN, USA). 
Interferon gamma (IFNγ) was determined using ELISA (R&D system; Minneapolis, 
MN, USA). IL-22 was assayed using Duoset-Elisa from R&D system. 
Identification of Microorganisms by Peptide Nucleic Acid Fluorescence in situ 
Hybridization 
Sinonasal tissues were prepared using frozen section procedure and cut to  
5 μm, fixed with 70% ethanol for ten minutes and air-dried. Subsequently, the dried 
sections were hybridized at 55 °C for 90 minutes in a humidified chamber with 100–
500 nM of fluorescein-labeled PNA probe and hybridization buffer. All the PNA 
probes and buffer solutions were taken from the PNA-FISH kit from AdvanDx; 
Woburn, MA, USA. We employed Uniprobe to hybridizes with a wide range of 
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gram positive and gram negative bacteria. For S. aureus, P. aeruginosa and E. coli 
we used appropriate probes. A panFungal PNA probe was used to detect a wide 
range of fungi. After hybridization, the coverslips were removed by submerging 
each slide in the stringent wash buffer and washed for 30 minutes in a shaking water 
bath at 55°C. Each slide was subsequently mounted in Vectashield (Vector; 
Burlingame, CA, USA) containing 4,6-diamidino-2-phenylindole dihydrochloride 
(Roche Molecular Biochemicals; Brussels, Belgium) to counterstain the nuclei. A 
negative control (without PNA probe) was run in parallel to each sample. 
Microscopic examination was conducted with a Zeiss Axioplan epifluorescence 
microscope (Carl Zeiss; Gottingen, Germany) equipped with a CCD camera 
(IMACCCD S30; SONY, Germany) using a fluorescein isothiocyanate specific 
filter. Images were captured using the Isis imaging and software system 
(MetaSystems; Sandhausen, Germany). The samples were assessed using a score of 
bacterial appearance in the mucosa from 0 to 3: 0, negative; 1, extraepithelial 
presence; 2, intraepithelial presence and 3, subepithelial presence (Fig 1). Ten high-
power fields were counted and added resulting in a total mucosal score between 0 
and 30. Furthermore, we interpreted mucosal invasion as; negative (all 10 fields 
scored 0), noninvasive (at least 1 field scored 1), or intramucosal invasive (at least 1 
field scored 2 or 3) based on the maximum score. Two independent observers, not 
privileged to the diagnosis and clinical data, evaluated the slides. 
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Figure 1. Detection of microorganisms in sinonasal tissue with peptide nucleic 
acid‐fluorescence in situ hybridization. The figures show autofluorescence of the 
sinonasal epithelium; without the postive staining (A), with extraepithelial presence 




Statistical analysis was performed with GraphPad Prism version 6.00 for 
Mac OS X (GraphPad Software; La Jolla CA, USA, www.graphpad.com). The 
categorical data (sex, positive atopy, asthma, and probe) were expressed as 
frequencies or percentages and were analyzed using the Chi-square test. The interval 
data (age, level of cytokines, and total mucosal score) were tested for distribution 
using the Shapiro-Wilk normality test revealing that the data were distributed non-
normally. The Kruskal-Wallis test was used to assess the significance of intergroup 
correlation, and corrections of significance for between-group comparisons were 
calculated using Dunn's test. The Spearman’s rank correlation was employed to 
assess the statistical correlation between cytokine and mucosal score. The statistical 
significance level was determined as p <0.05. 
Results 
Characteristics in the Nasal Tissue Samples 
Table 1 illustrates the number of samples and clinical characteristics of the 
patients. More than half (62.5%) of the CRSwNP patients with IL-5 and SE-IgE 
positive had co-morbid asthma. CF patients were the youngest as expected. No 
significant differences were found with regard to sex and atopy in intergroup 
comparisons of patients. 
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No. of samples 20 20 20 20 20 15 
Mean age  (yr) 32.75 44.45 39.35 41.05 51.2 13.25 < 0.0001 




5.88% 20% 31.25% 29.41% 52.94% n/a NS 
(0.6776) 
Asthma 0 % 20% 20% 35.29% 62.50% n/a 0.0330 
Cytokine Patterns in the Sinonasal Tissue Samples 
Typical patterns of cytokines of sinonasal tissues from CRSsNP patients 
are T helper 1(Th1)-driven, whereas sinonasal tissues with eosinophilia from 
CRSwNP patients are T helper 2(Th2)-biased. Non-eosinophilic sinonasal tissues 
from CRSwNP patients express increased amounts of IFNγ and/or IL-17 or none of 
those. Sinonasal tissues from CF patients demonstrate high concentrations of IL-17 
and IL-8 5. In the current study, concentrations of ECP and IgE were significantly 
higher in sinonasal tissues from CRSwNP patients with IL-5 expression than those 
all other groups. Additionally, an increase in SE-IgE concentration was observed. 
The number of SE -IgE positive subjects was significantly higher in this group than 
those in the controls and the other groups. TNFα was detected in sinonasal tissues 
from CRSsNP patients and CRSwNP patients with IL-5 positive tissues. IFNγ was 
noted in the sinonasal tissue homogenates with a concentration of TNFα >20 pg/ml 
from CRSsNP patients, IL-5 negative sinonasal tissues from CRSwNP patients, and 
sinonasal tissues from CF patients. The expression of IL-22 showed a significant 
increase in the TNFα >20 pg/ml sinonasal tissue homogenates from CRSsNP 
patients compared with those of all other groups. A remarkably decreased level of 
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IL-22 was observed in sinonasal tissues from CF patients compared with those in 
the control and sinonasal tissues from CRSsNP patients. Although IL-17 expression 
was higher in sinonasal tissues from CF patients, it did not reach the level of 
statistical significance (p = 0.0545)(Fig 2). 
Figure 2. Cytokine expression in sinus tissues. The graphs represent median, 
upper and lower quartiles. High IgE, IL-5 and ECP concentrations characterize the 
inflammation in CRSwNP:IL5&SE-IgE positive. In CRSsNP: TNFα >20 pg/mL, the 
expression of IFNγ and IL-22 are elevated.  
Statistical analysis was performed using Kruskal-Wallis and Dunn’s multiple comparisons 
test. *: p value ≤ 0.05. **: p value between 0.001 and 0.01, ***: p values between 0.0001 
and 0.001, ****: p value < 0.0001. BDL stands for Below Detection Limit. 
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PNA-FISH Probe Results 
The detection rate of S. aureus was significantly higher in sinonasal tissues 
from CRSwNP patients with IL-5 and SE-IgE (75%) and CF patients (60%) than 
those from the control patients (15%, p = 0.0001 and p = 0.0055 respectively). The 
presence of P. aeruginosa in samples of sinonasal tissue from CRSsNP patients with 
TNFα concentrations > 20 pg/ml group (70%) was significantly higher than in the 
control group (35%, p = 0.0267). The PNA-FISH probe for E. coli and panfungus 
revealed no statistically significant difference among all groups. Furthermore, the 
Uniprobe discovering all bacteria did not show any difference in numbers, 
indicating that all samples had about the same total bacterial load. Representative 
PNA probe findings are shown in Figure 3. 
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Figure 3. PNA-FISH. Percentages of samples of bacterial presence for each of the 
probes in the different patient groups. Differences from the control group were 
calculated using the Chi-square test. *: p value ≤ 0.05. **: p value between 0.001 
and 0.01, ***: p values between 0.0001 and 0.001. 
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The total mucosal scores (median [interquartile range]) for S. aureus in the 
CRSwNP:IL-5 and SE-IgE positive group (3 [0-13]) and CF group (3 [0-19]) were 
significantly different from that in the control group (0[0-7]). Asthma had no 
significant impact on the scores in the CRSwNP:IL-5 and SE-IgE positive group. 
Invasion of the mucosa by P. aeruginosa was significantly more frequent in the 
CRSsNP:TNFα > 20 pg/ml group (median 8 [0-15]) than that in control group 
(median 0 [0-6]) (Fig 4). 
Figure 4. Total mucosal scores for the presence of bacteria in sample tissues, 
detected by PNA-FISH Each point represents the score from the individual sample. 
The data for each group are expressed as median and interquartile range. The 
significance between groups was tested using Kruskal-Wallis test. Dunn’s test was 
employed to correct the significance for between-group comparisons. 
*: p value ≤ 0.05. **: p value between 0.001 and 0.01. 
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Correlations between Cytokine Levels and Total Mucosal Score 
Correlations of cytokines and scores of bacterial appearance in the mucosa 
reveal that IL-5 and ECP were positively correlated with the S. aureus score (r 
=0.2181, p = 0.0293; and r = 0.3417, p = 0.0025, respectively). In contrast, IL-22 
was negatively correlated with the S. aureus score (r = -0.3033, p = 0.0012). The P. 
aeruginosa score positively correlated with TNFα (r = 0.2495, p = 0.0276) and IFNγ 
(r = 0.2839, p = 0.0025). However, no cytokine detectable in tissue correlated with 
the Uniprobe score (Fig. 5). 
Figure 5. (adjacent page) Correlation between cytokines and total mucosal 
scores for all bacteria (UniProbe), and for S. aureus and P. aeruginosa, on the 
basis of PNA-FISH.  
The correlations were calculated using Spearman’s rank test. Correlation coefficient 




In this study, we employed the PNA-FISH assay to detect intra-cellular 
bacteria in sinonasal tissue from six groups. As a result, we have identified a 
relationship between intramucosal microorganisms and inflammatory patterns in 
several subgroups of CRS patients. We demonstrated that S. aureus was present in 
sinonasal tissues from IL-5 and SE-Ig E positive CRSwNP patients and sinonasal 
tissues from patients with CF. P. aeruginosa was specifically found in the sinonasal 
tissues of CRSsNP patients with TNFα concentrations above 20 pg/ml. 
S. aureus, a gram-positive coccus, expresses a range of virulence factors 
that challenge the immune system 6. Our results are consistent with earlier findings 
that S. aureus could drive Th2 type inflammation 2,4,7. The association of S. aureus 
superantigens and CRSwNP disease was recently confirmed in a meta-analysis 8. 
Furthermore, our findings confirm that S. aureus colonizes the airways of young 
patients with CF 9. However, mucosal S. aureus enterotoxin-specific IgEs could be 
found in adult patients with CRSwNP, those antibodies could not be detected in 
sinonasal of patients with CF. The reasons for this observation may lie in the ability 
of S. aureus to produce enterotoxins or in the immunological environment. For 
CRSwNP patient, the presence of IL-5 and SE-Ig E but not S. aureus in tissue was 
associated with comorbid asthma 3,10. Moreover, the level of IL-5 and SE-Ig E was 
demonstrated to be significantly increased in recurrent versus nonrecurrent 
CRSwNP disease 11. 
P. aeruginosa is a gram-negative, motile rod bacterium. This study 
revealed the clinically meaningful presence of P. aeruginosa in sinonasal tissues of 
CRSsNP patients with TNFα concentrations higher than 20 pg/ml, coinciding with 
elevated levels of IFNγ and IL-22. These findings confirm a Th1 milieu in CRSsNP 
disease and suggest that P. aeruginosa may drive Th1 type inflammation and a 
specific antibacterial response 12. P. aeruginosa does not only stimulate TNFα 
production in epithelial cells 13, but also induces dendritic cell maturation to the 
Th1-polarizing phenotype 14. Moreover, P. aeruginosa activates dendritic cells, Th1 
cells, and group 3 innate lymphoid cells (ILC) in the mucosa to produce IL-22 15,16. 
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IL-22, a member of the IL-10 family 17 is essential for mucosal immunity. It boosts 
the innate immunity 16 and induces epithelial cells to produce antimicrobial proteins 
18.
In murine models, IL-22 was demonstrated to play a vital role in the fight against
gram-negative bacteria in the respiratory system 19,20. The decreased expression of 
IL-22 in sinonasal tissues from CF patients may predispose these patients to gram-
negative infection in adults.  
This study illustrated that intramucosal P. aeruginosa colonization relates 
to TNFα and IFNγ levels in the sinonasal tissue. TNFα has been defined as a key 
regulatory cytokine of inflammatory responses and plays an important role of 
normal host defense against microorganisms 21. Our data suggest that either TNFα 
or IFNγ may serve as markers for P. aeruginosa infections in CRSsNP disease. 
Using FISH with the Uniprobe, we found equivalent amounts of bacteria in 
control and diseased tissues. This is in agreement with recent findings on the sinus 
microbiome, showing similar results 22. The number of microbiota per surface area 
may be similar, the richness and evenness of these microbiota differentiate healthy 
conditions from diseased conditions. The intramucosal presence of bacteria has been 
not only demonstrated before in disease, but also in healthy conditions 3,23. 
The prevalence of fungi in CRS disease has long been considered. In our 
series, the pan-fungal PNA-FISH probe only detected a small proportion of fungi 
without differences between groups 24. Although studies have reported a 
predominance of fungi in CRS patients 25,26, the prevalence of fungal DNA in CRS 
patients was shown to be lower than 10% 27. It should be taken into account that we 
may have slightly underestimated the number of fungi present due to the failure of 
PNA-FISH probes to penetrate the rigid fungal cell walls 28. This study does not 
support the hypothesis that fungi are principal offenders in the development of CRS 
disease. 
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Future directions for research should involve 16S rRNA gene 
pyrosequencing and quantitative real-time PCR approaches and study the immune 
proteomes of the germs and the pathomechanisms involved in the crosstalk with the 
host. Exploration of the relationships between microbes and their impacts on 
sinonasal immune responses may lead to a greater understanding of the pathogenesis 
of CRS, and thus, result in new strategies for its treatment.  
Conclusion 
For the first time, this study identified a relationship between intramucosal 
microorganisms and inflammatory patterns in subgroups of patients with CRS. 
Variations of intramucosal bacteria have been identified between the different CRS 
endotypes. S. aureus is associated with Th2-bias CRSwNP tissue and sinonasal 
tissues from patients with CF while P. aeruginosa is related to high inflammatory 
CRSsNP disease. We propose TNFα and/or IFNγ as a biomarker for CRSsNP 
disease. The interaction of microbes with the mucosal immune responses should be 
further evaluated. 
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Abstract 
Chronic rhinosinusitis with nasal polyp (CRSwNP) patients are often 
characterized by asthma comorbidity and a type-2 inflammation of the sinonasal 
mucosa. The mucosal microbiota has been suggested to be implicated in the 
persistence of inflammation, but associations have not been well-defined. To 
compare the bacterial communities of healthy subjects with those of CRSwNP 
patients, we collected nasal swabs from 17 healthy subjects, 21 CRSwNP patients 
without asthma (CRSwNP-A), and 20 CRSwNP patients with co-morbid asthma 
(CRSwNP+A). We analysed the microbiota using high-throughput sequencing of 
the bacterial 16S rRNA. Bacterial communities were different between the three 
groups. Haemophilus influenzae was significantly enriched in CRSwNP patients, 
Propionibacterium acnes in the healthy group; Staphylococcus aureus was abundant 
in the CRSwNP-A group, even though present in 57% of the patients. Escherichia 
coli was found in high amounts in CRSwNP+A patients. Nasal tissues of 
CRSwNP+A patients expressed significantly higher concentrations of IgE, SE-IgE, 
and IL-5 than those of CRSwNP-A patients. Co-cultivation demonstrated that P. acnes 
growth was inhibited by H. influenzae, E. coli and S. aureus. The nasal microbiotas of 
healthy subjects are different from those of CRSwNP-A and CRSwNP+A patients. 




Chronic rhinosinusitis with nasal polyps (CRSwNP) is defined as a 
subgroup of chronic rhinosinusitis (CRS) characterized by the presence of fleshy 
swellings (nasal polyps) that develop in the lining of the nose and paranasal sinuses1. 
Nasal polyps (NP) are believed to arise in the nasal mucosa because of chronic
inflammation. In central Europe, CRSwNP is mostly characterized by a moderate to 
severe T helper type 2 (Th2)-mediated inflammation with hypereosinophilia and 
increased IgE concentrations. CRSwNP is difficult to treat and recurrences are 
frequent, despite medical treatment and surgical interventions. In addition, patients 
suffering from CRSwNP often have comorbid diseases, such as asthma and aspirin 
intolerance 2,3. 
The definitive mechanisms underlying the pathogenesis of CRS remain 
poorly elucidated 4. Microbial involvements have been considered to be one of the 
mechanisms contributing to the inflammation in case of CRS 5,6, whereas in some 
reports the characteristics of sinus microbiota in CRS were similar to those of 
control groups 7-9, other analyses, making use of CRS phenotypes or endotypes, 
demonstrated different compositions of resident sinus bacterial communities 6,10. 
Our group has previously demonstrated that Staphylococcus aureus is able to drive 
Th2 type inflammation and that it is associated with Th2-biased CRSwNP 5,6,11. We 
have also reported that the expression of IL-5 and of IgE against S. aureus 
superantigens (SE-IgE) within polyp tissue is associated with comorbid asthma 12,13. 
Furthermore, the levels of IL-5 and SE-IgE were significantly increased in recurrent 
versus non-recurrent CRSwNP 14 and several studies suggest that alterations in the 
airway microbiota may be associated with inflammatory processes 6,7,10,15-17. We 
therefore reasoned that a study with well-defined subgroups of CRS patients could 
possibly identify different microbiota, which might be related to specific 
pathological or immunological characteristics of the inflammation. 
Here, we hypothesized that heterogeneousness of CRSwNP with regard to 
asthma comorbidity could be associated with the presence of compositionally 
distinct sinus microbiota which affect host immune responses. To validate this 
hypothesis, we collected nasal swabs to obtain a suitable biological sample from the 
middle meatus, the common location of nasal polyps 18, from CRSwNP patients 
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without co-morbid asthma and then compared their sinus microbiota to that of 
patients with CRSwNP with co-morbid asthma and to that of healthy control 
subjects, using 16S ribosomal RNA-gene (16S rRNA gene) high throughput 
sequencing. Furthermore, we studied the in vitro inhibitory and/or stimulatory 
effects of isolated strains of different species on each other, specifically to 
understand to what extent the species that are most frequently present in control 
subjects may protect the mucosa against germs most frequent in patients with 
CRSwNP.  
Materials and Methods 
Study Design and Population 
We evaluated nasal microbiota from non-asthmatic CRSwNP patients, 
CRSwNP patients with co-morbid asthma, and healthy control subjects. Diagnosis 
of CRSwNP was made according to the European Position Paper on Rhinosinusitis 
and Nasal Polyps 19. Diagnosis of asthma was confirmed by a pulmonologist. The 
atopic status was evaluated by skin prick tests to common inhalant allergens. The 
control group consisted of healthy volunteers and patients who were free from 
rhinosinusitis, asthma, and atopy. Patients less than 18 years of age, subjects with 
cystic fibrosis, known or suspected immunodeficiency or autoimmune disease, and/
or suspected of the use of systemic antibiotics or oral steroids in the last three 
months before sample collection, were excluded from this study. 
Ethics Statement 
This study was approved by the ethics committee of the University of 
Ghent, Belgium and assigned number B670201422215. All participants provided 
written informed consents prior to their participation in the project. All experiments 
were performed in accordance with relevant guidelines and regulations. 
Sample Collection 
Specimens were collected at the Ghent University Hospital, Belgium. Swab 
specimens for DNA extraction were obtained with eSwab (COPAN, Brescia, Italy). 
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Swabs were endoscopically guided to the middle meatus region and rotated at least 
3 times. In addition, sinonasal tissue samples were obtained from the patients during 
endoscopic sinus surgery. All samples were immediately transported to the 
laboratory and snap frozen in liquid nitrogen and stored at -80°C until further 
analysis. 
Measurement of Cytokines in Sinonasal Tissue Samples 
Snap-frozen tissue specimens were weighed and suspended in a ratio 0.1 g 
of tissue per 1 mL of 0.9% NaCl solution with a complete protease inhibitor cocktail 
(Roche, Mannheim, Germany). To prepare soluble protein fractions, frozen tissues 
were mechanically pulverized using a Tissue Lyser LT (Qiagen, Hilden, Germany) 
at 50 oscillations per second for two minutes in prechilled Eppendorf tubes. 
Homogenized tissues were centrifuged at 1,800x g for ten minutes at 4 °C, and the 
supernatants were collected. Total IgE, eosinophil cationic protein (ECP) and 
specific IgE to staphylococcal enterotoxins (SE-IgE) were measured using the 
UniCAP system (Thermo Fisher Scientific, Phadia, Uppsala, Sweden). Tumor 
necrosis factor-alpha (TNF), interleukin (IL)-5 and IL-17 were quantified using the 
Bio-Plex 200 System (Bio-Rad, Temse, Belgium). 
DNA Extraction and Bioinformatic Analysis 
DNA was extracted from the whole swab using the FastDNA Spin kit (MP 
Biomedicals, Solon, Ohio) according to the manufacturer’s instructions. Total DNA 
concentration was measured with a NanoDrop ND-1000 spectrophotometer (Isogen 
Life Sciences, IJsselstein, The Netherlands). The quality of the extracted DNA was 
evaluated on a 1 % agarose gel. Libraries were prepared as previously described 20, 
using the primers 27F and 338R 20 for the V1-V2 region of the 16S rRNA gene. 
Libraries were sequenced on a MiSeq (Illumina, Hayward, California). Each 
sequence was identified using the SILVA database 21. Definition of operational 
taxonomic units (OTUs) and data-set quality filter was performed as previously 
described 20. After quality filtering, the dataset was then filtered to consider only 
those OTUs sequences that were present in at least one sample at a relative 
abundance of > 0.1% or that were present in all samples at a relative abundance of  
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>0.001%. All samples were randomly re-sampled to equal the smallest read size of 
6,682 reads, using the PhyloSeq package 22 from the free software R package for 
statistical computing and graphics 23. All the reads were grouped into 942 
sequences. All sequences were assigned a taxonomic affiliation (phylotype) based 
on the naive Bayesian classification (RDP classifier) 24. A genus name was assigned 
to a sequence when only 16S rRNA gene fragments of previously described isolates 
belonging to that genus and of 16S rRNA gene fragments originating from 
uncultured representatives of that genus showed ≤ 2 mismatches. Species 
assignments were performed using the Basic Local Alignment Search Tool 
(BLAST). Assignation of a name demanded at least 99% sequence identity over 
95% of sequence length 25. 
Statistical Analysis 
Statistical analysis was performed using GraphPad Prism version 6.00 for 
Mac OS X (GraphPad Software, La Jolla, CA: www.graphpad.com). The 
categorical outcomes (presence/absence of condition) were expressed as frequencies 
or percentages and were analyzed using the Chi-square test. The interval data (age, 
level of cytokines) were tested for distribution using the Shapiro-Wilk normality 
test. Assessment of the significance of intergroup correlation was performed using 
the parametric test for Gaussian distributed data and a non-parametric method for 
non-normally distributed data. The ecological profiles were analyzed using the 
PAST3 program 26. All Principal Coordinate Analyses (PCoA) were based on a 
Bray-Curtis similarity index, which operated at the phylotype level. To test for 
community compositional differences, permutation multivariate analysis of variance 
(PERMANOVA) was employed. Similarity Percentage (SIMPER) analysis was 
used to determine the contribution of each species to the observed dissimilarity 
between samples and to identify the species that are most important in creating the 
observed pattern. In each group, the 20 bacterial species with the highest relative 
abundance were selected. This resulted in 22 different bacterial species for further 
analyses. The difference of relative abundance was calculated using a nonparametric 
Kruskal-Wallis test and corrections of significance for between-group comparisons 
were calculated using Dunn’s test. The Spearman’s rank correlation was employed 
96 
to assess the statistical correlation between cytokine and bacterial relative 
abundance. The statistical significance level was determined as p < 0.05. 
Bacterial Cultivation and Interaction Assays 
An agar diffusion test (Kirby–Bauer method) was employed to determine 
in-vitro interaction between bacterial strains. The bacterial strains were selected 
based on metagenomic and clinical data. In a separate group of patients (10 healthy 
control subjects, 10 CRSwNP-A patients, and 10 CRSwNP+A patients) we found 
that the majority of S. aureus strains isolated from CRSwNP patients expressed 
accessory gene regulator (agr) group I and agr group II. Reference strains 
expressing agr group I and II were therefore used in this assay. Staphylococcus 
aureus (gfp RN6390 and ATCC 29213), Escherichia coli (O157:H7 strain), 
Haemophilus influenzae (ATCC 49144), Corynebacterium pseudodiphtheriticum 
(CIP 103420T), and Propionibacterium acnes (ATCC 6919) were selected for the 
experiment. Chocolate agar plate inoculation and incubation at 37 ºC with 5% CO2 
was determined to be the culture condition that enabled proficient growth of all 
bacterial strains. Bacterial colonies were harvested, resuspended in 0.9% NaCl to a 
turbidity that was adjusted to a 0.5 McFarland standard. To test for evidence of 
cooperative or competitive interaction of bacteria, twelve culture plates were used, 
of which six were smeared uniformly with 0.5 McFarland suspensions of each of the 
six test strains to obtain confluent growth (inoculated plate) and the other six were 
not inoculated (control plates). After left to dry for 5 minutes, 10 µl of 0.5 
McFarland standard suspensions of all six test strains were spotted on all culture 
plates. Agar plates were inspected at day 1, 2, 3, 5 and 7 for bacterial growth on the 
spots and also around the spots for the inoculated plates. The amount of growth of 
the spotted strains on the inoculated plates was compared to that on the control 
plates. Criteria for interpretation were established based on ecological interactions 
27,28. The nine possible interpretations of the interactions, ranging from mutually 
beneficial through neutral to spiteful interactions, are outlined in Table 1. 
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Table 1. Criteria for interpretation of bacterial interaction.  
Legend:  >: more growth of inoculated strain on inoculated plate than control plate, 




Top growth (spots on top of inoculated plate) 











Characteristics of the Patients 
Fifty-eight adults [17 healthy control subjects, 21 CRSwNP patients 
without asthma (CRSwNP-A), and 20 CRSwNP patients with co-morbid asthma 
(CRSwNP+A)] were enrolled in the study. Table 2 illustrates clinical characteristics 
of the participants. No significant differences with regard to age or gender were 
found among the three groups. Atopic status and aspirin intolerance were 
significantly more prevalent in the CRSwNP+A group, as expected. According to 
severity of disease based on visual analogue scales for symptoms (VAS), 
CRSwNP+A patients had remarkably more trouble with nasal congestion and mucus 
than CRSwNP-A patients (Fig.1). 
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Figure 1. Visual analogue scale. The figure shows the symptom profile and 
symptom severity of the two patient groups. Nasal congestion and mucus scales 
were significantly higher in asthmatic patients than non-asthmatic patients. 
Statistical analysis was performed using Mann-Whitney test. 
Legend: *: p < 0.05; **: p < 0.01. 
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Table 2. Characteristics of control and patient groups 
Control CRSwNP-A CRSwNP+A 
Statistical 
analysis* 
Number of subjects 17 21 20 
Mean age (yr) 44.94 47.52 45.75 p = 0.8688 
Male/Female 9/8 10/11 12/8 p = 0.7285 
Atopy status positive (%) 0 19 80 p < 0.0001 
Aspirin intolerance (%) 0 0 33.33 p = 0.0014 
Legend: *: statistical test used. Kruskal-Wallis test for Age. Chi-square test for 
gender, Atopy status, and Aspirin intolerance. 
Cytokine Patterns in the Sinonasal Tissue Samples 
Nasal polyp (NP) disease in European patients is mostly characterized by 
an infiltration of eosinophils and expression of high concentrations of ECP. In this 
study, Th2 related mediators and cytokines (IgE, SE-IgE and IL-5) were 
significantly increased in NP from asthmatic patients compared with those of non-
asthmatic subjects, as shown in Fig.2. For example, median total IgE in the 
CRSwNP-A group was 440.4 kU/L (interquartile ranges IQRs: 101-742.5) 
compared to 1543 kU/L (IQRs: 640-2321) in the CRSwNP+A group (Table 3). The 
level of ECP, TNFα, and IL-17 showed no significant differences between groups. 
Furthermore, the SE-IgE positive group showed notable higher concentrations of 
IgE (median in the SE-Ig E positive subjects 1307 kU/L vs. 252 kU/L in SE-Ig E 
negative subjects, p < 0.0001), IL-5 (701 pg/mL vs. 77 pg/mL, p < 0.01), and ECP 
(29920 μg/L vs. 14045 μg/L, p < 0.01) than in the SE-IgE negative group.  
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Table 3. Cytokine concentrations of homogenized tissue: CRSwNP-A versus 
CRSwNP+A 
Cytokine (unit) CRSwNP-A CRSwNP+A p-value 
IL-5 (pg/mL) 63.1 (24.3-150.7) 634.3 (73.6-1639) 0.0018 
ECP (μg/L) 15274 (4343-23654) 24486 (10672-32109) 0.0922 
Ig E (kU/L) 440.4 (101-742.5) 1543.0 (640-2321) 0.0008 
SE-IgE (kU/L) 1.9 (1.9-1.9) 8.0 (5.9-11.4) <0.001 
TNF-α (pg/mL) 25.1 (3.4-48.9) 30.1 (15.8-50.4) 0.7898 
IL-17 (pg/mL) 32.0 (1.1-154) 28.4 (1.1-54.7) 0.5628 
Values are expressed as median (interquartile ranges); differences between groups 
are determined using Mann-Whitney test. 
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Figure 2. Cytokine expression in nasal polyps tissues. The graphs show median, 
upper and lower quartiles. High IgE, SE-IgE and IL-5 concentrations characterize 
the inflammation in NP from asthmatic patients. Statistic results were calculated 
using the t-test for Gaussian-distributed data and the Mann-Whitney test for non-
normal distribution. 
Legend: *: p < 0.05; **: p < 0.01; ***: p < 0.001; ****: p < 0.0001. 
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Microbial Diversity and Relative Abundances of Bacterial Species 
Bacterial DNA was detected in all middle meatal swab samples. The 
number of phylotypes varied from 26 to 207 per sample with an average of 113 
phylotypes in the control group, 116 phylotypes in the CRSwNP-A group, and 109 
phylotypes in the CRSwNP+A group. Regarding the total number of reads of 16S 
rRNA gene, there was no statistically significant difference among the three groups, 
indicating that control subjects and CRSwNP patients had about the same total 
bacterial load. The sinonasal microbiota of CRSwNP as a group, regardless of co-
morbid asthma, however showed significantly decreased bacterial diversity 
(Shannon H index: a mathematical measure of species diversity in a given 
community based on the species richness and species abundance) and evenness 
(Pielou’s evenness index: how close in numbers each species in an environment is.), 
when compared with those of the control group. Especially, the CRSwNP-A group 
exhibited significantly reduced bacterial evenness and Shannon’s diversity when 
compared with the control group. No significant differences were found with regard 
to Chao-1 species richness indexes (the number of unique species per sample) in 
intergroup comparisons (Fig.3). 
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Figure 3 Biodiversity indices. The graphs compare diversity indices (richness, 
Shannon diversity, and evenness) between healthy control subjects and patients with 
CRSwNP-A and CRSwNP+A. Statistical analysis was performed using Kruskal-
Wallis and Dunn's multiple comparisons test.  
Legend: *: p < 0.05; **: p < 0.01; ***: p < 0.001. 
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The phylum-level structure is depicted on Fig.4. With respect to health and 
disease status, the genus Haemophilus was more abundance in CRSwNP disease 
than healthy control, while the genus Bacteroides was dominant in healthy control 
subjects when compared with CRSwNP cases. At the species level, Haemophilus 
influenzae was significantly more abundant in CRSwNP patients than in healthy 
control subjects (Fig. S1a). Corynebacterium pseudodiphtheriticum was more 
prevalent in diseases when compared with controls. Staphylococcus xylosus and 
Bifidobacterium longum were more prevalent and abundant in the control group 
than in the CRSwNP group. 
Figure 4. Bacterial community composition in each subject at the phylum level.  
Legend: C:  healthy control subject, P: CRSwNP-A subject, A: CRSwNP+A subject. 
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Principal coordinate analysis (PCoA) ordination depicted sinus bacterial 
beta diversity between samples (Fig.5). One-way PERMANOVA with Bray-Curtis 
index detected statistically significant differences of bacterial communities in 
intergroup comparisons (Holm-Bonferroni sequential corrected p-values < 0.001). A 
post-hoc pairwise comparison revealed differences in microbial composition 
between control and CRSwNP+A groups (p < 0.01), control and CRSwNP-A 
groups (p < 0.01), and between CRSwNP patients (p < 0.03). 
Figure 5. PCoA plot of Bray-Curtis distance between healthy control subjects 
(green dot), CRSwNP-A patients (blue square) and CRSwNP+A patients (red 
triangle). 
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Considering the bacterial composition at the phylum level (Fig.6), 
Actinobacteria were more abundant in the healthy control subjects than those in 
patients with CRSwNP+A and the average abundances of Bacteroidetes and 
Cyanobacteria were notably higher in healthy control subjects than in CRSwNP-A 
patients. Proteobacteria predominated in CRSwNP+A group compared with 
CRSwNP-A and control group.  
Figure 6. Phylum-level differences between groups. Dot graphs show relative 
abundance of bacterial phyla from each sample. Kruskal-Wallis and Dunn's multiple 
comparisons were employed for statistical analysis. 
Legend: *: p < 0.05; ** p < 0.01. 
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At the genus levels, CRSwNP-A patients carried significantly higher 
abundance of Corynebacterium (p = 0.04) (phylum Actinobacteria) and Geobacter 
(p < 0.01) (phylum Proteobacteria) than those in CRSwNP+A patients (Fig.7). There 
was no significant difference between healthy control subjects and CRSwNP-A 
patients and between healthy control subjects and CRSwNP+A patients. 
Figure 7. Heatmap analysis of the most abundant bacterial genera. The heatmap 
shown in white-to-red represents relative abundance that discriminates groups. The 
difference of abundance was calculated using a nonparametric Kruskal-Wallis test 
and corrections of significance for between-group comparisons were calculated 
using Dunn's test. Asterisks denote significant p-values. 
Legend: *p < 0.05, and **p < 0.01. 
Genus
p-value  C vs P   C vs A   C vs P
Phylum
Staphylococcus 0.1627 ns ns ns Firmicutes
Corynebacterium 0.0412 ns ns * Actinobacteria
Haemophilus 0.0888 ns ns ns Proteobacteria
Escherichia 0.4487 ns ns ns Proteobacteria
Propionibacterium 0.2398 ns ns ns Actinobacteria
Streptococcus 0.7878 ns ns ns Actinobacteria
Moraxella 0.4712 ns ns ns Proteobacteria
Geobacter 0.0035 ns ns ** Proteobacteria
Pseudomonas 0.1317 ns ns ns Proteobacteria
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At the species level (Fig.8), CRSwNP+A subjects had a higher prevalent 
and abundant of Moraxella catarrhalis than those in CRSwNP-A subjects, whereas 
CRSwNP-A subjects had a higher abundance of Geobacter 
anodireducens/sulfurrreducens and Pelomonas puraquae than those in CRSwNP+A 
patients. All aforementioned species are member of the phylum Proteobacteria. 
CRSwNP-A patients had a significantly lower prevalence of M. catarrhalis, S. 
aureus and Staphylococcus xylosus than those in the other groups (p < 0.05). The 
mean relative abundance of S. xylosus was also notably lower in CRSwNP-A group 
than those in the other groups. Compared to healthy control group, the prevalence 
and relative abundance of Bifidobacterium longum was lower in CRSwNP-A group.  
Figure 8. Prevalence and relative abundance of the most abundant bacterial 
species. The heat maps in white-to-black and white-to-red depict the prevalence and 
relative abundance, respectively. The order was arranged based on the contribution 
to the observed dissimilarity. 
Legend: ns: no statistical significance (p ≥ 0.05); *: p < 0.05; **: p < 0.01; ***: 
p < 0.001; ****: p < 0.0001. 
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The prevalence and abundance within bacterial community is summarized 
in Figure 9. For example, S. aureus was prevalent in 94% of healthy control 
subjects, 57% of CRSwNP-A patients, and 90% of CRSwNP+A patients. The 
average relative abundance of S. aureus was 185 in the healthy group, 654 in the 
CRSwNP-A group, and 145 in the CRSwNP+A group. In the healthy control group, 
Propionibacterium acnes (phylum Actinobacteria) was the most abundant species. 
In the CRSwNP-A group had the highest abundance of S. aureus (phylum 
Firmicutes). In the CRSwNP+A group, Escherichia coli (phylum Proteobacteria) 
was found in high amounts. 
Figure 9 Prevalence and relative abundance within the bacterial community 
110 
Correlations between Cytokine Levels and Relative Abundance of Bacteria 
Comparison of cytokine levels with relative abundance of bacteria in the 
nasal polyps tissues revealed that ECP and IL-5 were negatively correlated with the 
phylum Actinobacteria (p < 0.05, r = -0.3652, and -0.3760 respectively). The 
phylum Bacteroidetes correlated positively with IL-5 (p < 0.02, r = 0.3969), but 
negatively with IL-17 (p < 0.01, r = -0.4632). 
At the species level, total IgE and IL-5 were negatively correlated with 
Geobacter anodireducens/sulfurreducens and Pelomonas puraquae, IL-5 was 
negatively correlated with Corynebacterium macginleyi, and ECP was negatively 
correlated with Corynebacterium accolens, C. macginleyi and Streptococcus 
pneumoniae. In contrast, ECP and IL-5 were positively correlated with E. coli. 
S. aureus and P. acnes were not correlated with any cytokine. IL-17 and TNF-α 
were not correlated with any of the top 20 bacterial species (Table 4). However, no 
single correlation reached a correlation coefficient of higher than 0.6 (moderate 
correlation). 
Table 4. Significant correlations between cytokines and relative abundance of 
top 20 bacterial species in the sinus microbiota of CRSwNP patients 
Species 
Immune marker: Coefficient (p-value) 
Total IgE ECP IL-5 
Bacteroides dorei 0.4472 (0.0062) 
Corynebacterium accolens -0.3880 (0.0213) 
Corynebacterium macginleyi -0.5658 (0.0004) -0.4030 (0.0148) 
Enterobacter cloacae 0.3393 (0.0461) 0.3377 (0.0439) 
Escherichia coli 0.4638 (0.0050) 0.4150 (0.0118) 
Geobacter anodireducens/ 
G. sulfurreducens 
-0.4510 (0.0058) -0.3704 (0.0262) 
Pelomonas puraquae -0.3563 (0.0330) -0.3526 (0.0349) 
Streptococcus pneumoniae -0.3539 (0.0370) 
111 
Interspecies Interactions of Cultured Bacterial Species 
When testing the possible interactions between six strains of five of the 
most frequently present species, we observed that growth of C. pseudodiptheriticum 
on the inoculated plate was enhanced by the presence of S. aureus RN6390 and H. 
influenzae, but retarded by E. coli and inhibited by S. aureus ATCC 29213. P. acnes 
appeared to be inhibitied by S. aureus (both strains), E. coli and H. influenzae. 
Furthermore, H. influenzae was inhibited by S. aureus ATCC 29213 and E. coli. 
Growth of S. aureus RN6390 was inhibited by E. coli. With respect to growth 
pattern of the strains used to initially inoculate the plates, C. pseudodiptheriticum 
swiftly flourished in the proximity of the E. coli inoculation point, whereas growth 
of P. acnes was inhibited around the inoculation point of S. aureus ATCC 29213. 
Neither growth inhibition nor growth promotion was noticed between C. 
pseudodiptheriticum and P. acnes, and between S. aureus ATCC 29213 and E. coli. 
Fig.10 demonstrates the observed bacterial growth patterns. Interspecies interplay 
on the basis of the available information from our in-vitro experiments is depicted in 
Fig.11 (Fig S2). 
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Figure 10. Record of bacterial growth in competitive experiments. Growth 
promotion and growth inhibition are highlighted by green and red circles, 
respectively. Growth of an inoculated strain on a smeared strain (upper left photo) 
compared to control plate (upper right photo): The red circles mark the absence of P. 
acnes growth on H. influenzae. The green circles show enhanced growth of C. 
pseudodiphtheriticum on H. influenzae. The growth of the smeared strain around the 
point of inoculation of a second germ is displayed in the lower photos. The green 
circle (lower left photo) shows enhanced growth of C. pseudodiphtheriticum 
surrounding the E. coli spot, whereas the red circle (lower right photo) points to a 
zone of inhibition of P. acnes around the S. aureus spot on chocolate agar. 
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Figure 11. Bacterial in vitro interactions. 
Legend: Red lines represent a negative relationship, green lines represent a positive 
relationship, and black lines represent neutral relationship. 
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Discussion 
The nasal bacterial community has been suggested to play a role in the 
development and severity of CRSwNP disease 29,30. The aim of this study was to 
establish whether and to what extent there might be differences in the nasal 
microbiota of healthy control subjects, compared to those of non-asthmatic and 
asthmatic CRSwNP patients. Subgrouping of the patients into endotypes was based 
on our previous studies 3,6. Indeed, CRSwNP disease can be further classified on the 
basis of distinct biomarkers (IgE, SE-IgE, and IL-5) that are increased in nasal 
polyps tissue when there is comorbidity (asthma). Different microbiota might 
represent different functional communities and invoke an immune response ranging 
from homeostatic to detrimental inflammatory effects, as such explaining the 
differences between the different endotypes. 
Aberrant bacterial community in CRSwNP disease. 
This study identifies that the relative abundance of H. influenzae is 
remarkably higher in CRSwNP cases than in normal subjects. Combining the 
experimental data from mice 31, the epidemiological data from humans 32, and our 
observation of an association of H. influenzae with CRSwNP, we hypothesize that 
H. influenzae can initiate and drive inflammatory responses to develop nasal 
polyposis and therefore it may be hypothesized that elimination of H. influenzae in 
an acute phase might reduce incidence of NP cases. It might further be assumed that 
success or failure of the antibiotic treatment of the acute phase infection might drive 
an ongoing inflammation into resolution or NP formation, respectively. 
In addition, the bacterial community in CRSwNP+A patients showed 
dominance of the phylum Proteobacteria, caused by unexpectedly high numbers of 
E. coli (Enterobacteriaceae), although not significantly different from the other two 
groups, whereas S. aureus was predominant in CRSwNP-A patients. Our findings 
concurred with a previous study that reported strong increase of Enterobacteriaceae 
in bronchial lavage of patients with asthma compared to those of control subjects 33. 
When we combined the data of members of the Proteobacteria (i.e. E. coli, H. 
influenzae, and M. catarrhalis), we could establish a significant increase in relative 
abundance of these bacteria for patients with CRSwNP+A compared to those of the 
control group (Fig.S1b). 
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Proteobacteria might contribute to the pathogenesis of CRSwNP disease 
via eicosanoids and related mediators 34. The abundance of E. coli in several 
CRSwNP+A patients and the positive correlation of E. coli with ECP and IL-5 
suggest a role of E.coli in severity of type 2 inflammation in CRSwNP patients.  
It is possible that E. coli impairs the epithelial barrier and cooperates with 
putative pathogens for initiation and amplification of type 2 inflammation in 
CRSwNP disease. 
Effect of microbial components on putative pathogens 
In the current study, the average relative abundance of S. aureus in 
CRSwNP-A patients is higher than that in healthy control subjects, but this is not the 
case for CRSwNP+A patients. The presence of specific IgE to staphylococcal 
enterotoxins (SE-IgE) is significantly more frequent in the CRSwNP+A than in the 
CRSwNP-A and control groups and correlates with disease severity. This 
observation supports the role of S. aureus and its immune proteome in the 
persistence of airway disease 35,36. Apparently, our findings seem to indicate that the 
composition of the bacterial community may influence the S. aureus virulence. The 
presence of large numbers of Actinobacteria (e.g. Corynebacterium spp.) in the 
environment might shift S. aureus to benign colonization, whereas increased numbers of 
Proteobacteria (predominantly E. coli) in the milieu might drive S. aureus to exhibit 
pathogenic behavior. It may be conceivable that bacterial composition and interactions in 
the community culminate in a functional community that organizes commensal-pathogen 
interchange. Intraspecific variability cannot be ruled out, whereby S. aureus strains present 
in healthy samples could differ from strains from samples from diseases patients. In one 
study, a strain of S. aureus inhibited other strains of the same species co-colonizing in nasal 
cavity 37. Various hypotheses were proposed to determine the regulation of S. aureus 
virulence, of which the global control of accessory gene regulator (agr) is the most 
promising one 38. We also identified strain-level variations of S. aureus, classified by agr, 
in an independent survey and in-vitro bacterial interaction experiments. S. aureus RN 6390 
belonging to agr group I and S. aureus ATCC 29213 agr group II. S. aureus agr group I 
had a positive impact on C. pseudodiptheriticum, whereas S. aureus agr group II had a 
negative impact on C. pseudodiptheriticum. Moreover, S. aureus agr group II killed 
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P. acnes in our experiments. A survey of S. aureus agr in higher numbers of patients 
should be conducted to confirm the possible importance of agr diversity of S. aureus in 
pathogenesis of CRS diseases. 
Corynebacterium species have been implicated as competitors with S. 
aureus in the nasal niche 39,40 or as tempering S. aureus virulence 41. One research 
group observed that C. pseudodiphtheriticum was present more often in non-S. 
aureus carriers than in S. aureus carriers 42. This group confirmed a competitive 
interaction between S. aureus and C. pseudodiphtheriticum 42, which is not 
supported by our data. We detected C. pseudodiptheriticum more frequently in the 
CRSwNP status. In addition, our in-vitro interactions rather indicated a positive 
cooperation between C. pseudodiptheriticum and putative pathogens, such as E. coli, 
H. influenzae and S. aureus (agr group I). 
Although several studies have described a negative association between S. 
aureus and S. epidermidis in the nasal cavity 43,44, our data did not show competition 
between S. aureus and S. epidermidis. 
Bacterial Associations with Inflammation in CRS 
A study using only 7 samples from CRS patients and a not-validated mice 
model concluded that Corynebacterium tuberculostearicum was a pathogen of CRS 
45, while another study reported that CRS patients with enriched C. 
tuberculostearicum colonization in their nose, at the time of endoscopic sinus 
surgery, showed better surgical outcomes 10. However, in our study neither a 
beneficial nor pathogenic role of C. tuberculostearicum can be concluded. We found 
that the distribution and relative abundance of C. tuberculostearicum was equivalent 
among groups. We also observed a negative correlation between eosinophilic 
activity in the tissue (i.e., ECP and IL-5) and other members of genus 
Corynebacterium (i.e., C. macginleyi, and C. accolens) that belong to phylum 
Actinobacteria. According to our previous study, the level of IL-5 is one of the 
prognostic factors in CRSwNP disease 14. These results suggest that members of 
phylum Actinobacteria, i.e.,Corynebacterium spp. (e.g. C. macginleyi), are 
associated with a lower degree of eosinophilic inflammation in CRSwNP patients. 
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Health-associated Microbes 
Several bacterial phyla were dominant in healthy individuals. The 
potentially beneficial microbe in the current study was a member of the phylum 
Actinobacteria; we found that Propionibacterium acnes was the most abundant 
microorganism in the healthy condition. Normally, P. acnes is a commensal microbe 
of adult human skin 46. P. acnes, which prefer a lipid-rich anaerobic environment, 
has been detected in sinonasal cavities of healthy adults 9,42,44,47. P. acnes has been 
described to promote Th1 and Treg cells and relieves atopic dermatitis symptoms 48, 
possibly by the production of short-chain fatty acids that are immunomodulating. 
Moreover, the principal metabolite of P. acnes, propionic acid, not only reduces 
inflammation by effects on macrophages 49, but also inhibits S. aureus growth 50. 
This argument nevertheless remained unsupported by our pilot study. The levels of 
propionic acid measured in the sinonasal environment did not reach the minimum 
inhibitory concentration of S. aureus. Furthermore, P. acnes did not prevent the 
growth of S. aureus, which in turn killed P. acnes to establish its own growth. These 
data do indicate that P. acnes is an commensal rather than a defender, although in-
vitro data regarding to bacterial interactions cannot be straightforwardly transposed 
to the in-vivo situation. P. acnes probably possess other factors for its fitness in 
healthy subjects. Healthy hosts may provide nutrients for P. acnes existence. Health-
associated microbes should be further investigated to identify a genuine probiotic 
for the treatment of CRS disease. 
This study provides a blueprint for identifying important microbial 
influencers of disease and provides information on the structure and members of 
nasal microbiota linked to specific clinical phenotypes and endotypes of CRSwNP 
disease (Fig.12). Our findings highlight the need for more functional studies on the 
bacterial community to determine the role of microbiota in CRS pathogenesis. 
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Figure 12. Aberrant bacterial community among groups. 
Limitations 
Several limitations should be addressed. This study was conducted using a 
limited number of samples, coming from patients who had prolonged medical 
treatment. Although we excluded patients that used steroids systemically, all 
CRSwNP patients may have taken intranasal steroid until shortly before the biopsy. 
The effect of steroids on bacterial communities remains unclear, although nasal 
irrigation with budesonide did not change the proportional abundance of bacteria in 
CRSwNP patients 51. We were concerned about the specificity of molecular 
techniques, even though it has been shown that the relative abundance of bacterial 
DNA had a positive correlation with colony-forming unit counts (CFUs) 30. 
Comparing recovered DNA to live colony counting, it appeared that in diseased 
subjects, Staphylococcus DNA mostly came from living bacteria, whereas in healthy 
subjects, Staphylococcus DNA was mostly recovered from dead bacteria 52. The 
method used here for microbiota may detect genetic material of non-viable 
microorganisms that distort the genuine microbial community composition. 
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Moreover, one bacterial cell carries from 1 up to 15 copies 16S rRNA gene copies 
per genome 53. The analysis of 16S rRNA can provide only the information of 
bacterial presence, but not metabolically active microorganism. The extraction and 
analysis of metagenomic mRNA (the metatranscriptome) or proteomic or 
metabolomic research should be further performed to assess the functional and 
metabolic diversity of microbial communities. Interplays between bacteria in our 
experiments are performed under in-vitro conditions. Although the tested strains 
were not directly isolated from the studied subjects, the selected strains were 
relevant to the situation in the human nose. We tested the interaction of only two 
species of bacteria. Interactions among the full spectrum of bacteria in-situ 
conditions may be different. The participation of the third, forth, and more species 
probably affects those bacterial behavior differently. A complementarily ecological 
theory would need to explain overarching interactions and patterns for the 
microbiota. Future research should explore functional parts of bacterial community 
and their impacts on the nasal mucosa. Investigations of bacterial communities and 
their impacts on sinonasal immune responses may pave the way for a better 
understanding of how the microbiota contribute to the pathogenesis of CRS. 
Conclusions 
This study identifies a difference in nasal microbiota between healthy 
subjects and phenotypes of CRSwNP patients. Proteobacteria (such as H. influenzae, 
E.coli, M. catarrhalis) were associated with CRSwNP disease, especially with 
CRSwNP+A cases, whereas Actinobacteria (such as P. acnes, Corynebacterium 
spp.) were prevalent in the healthy status. However, P. acnes, a resident commensal 
bacterium in healthy subjects, do not play the protective role against S. aureus one 
could expect from its abundance. Furthermore, although S. aureus was found 
abundant in CRSwNP-A, but not in CRSwNP+A, the presence of SE-IgE in the 
latter group representing its immunologic fingerprint rather than S. aureus itself is 
associated with disease severity. The functions of microbiota and their products in 
health and airway disease should be further elucidated to determine the effective 
role of microbiota in the pathomechanism of CRS disease. 
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Supplementary information 
Taxonomy of relevant bacteria in the study 
Phylum Genus Species 
Proteobacteria 
Haemophilus Haemophilus influenzae 
Escherichia Escherichia coli 









Streptococcus Streptococcus pneumoniae 
Actinobacteria 
Bifidobacterium Bifidobacterium longum 





Figure S1. Bacterial species that discriminate between groups (a) and among 
groups (b). 
The graphs show the relative abundance of discriminative species different between 
groups. Dots represent relative abundance in each sample.  
Legend: * p < 0.05, ** p < 0.01, and *** p < 0.001 
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Figure S2. Mutual inhibition and growth promotion between different bacterial 
species that are most abundant in controls and patient groups. 
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Chapter 8. Discussion 
Rhinosinusitis, an umbrella term for various kinds of inflammatory 
diseases of the nasal and paranasal cavities, is characterized by two or more 
symptoms. One is either blocked nose or running nose. The other one could be facial 
pain or pressure, reduction or loss of smell, or both. The illness gains a chronic 
status when the symptoms persist for three months without recovery despite being 
treated 1. Chronic rhinosinusitis (CRS) affects approximately 10% of the population 
in the United States and European countries 2,3. This malady can be classified into 
two clinical subgroups (phenotypes) based on the absence or presence of nasal 
polyps (CRSsNP and CRSwNP respectively) 1. This classification does not provide 
full insight into all underlying cellular and molecular pathophysiologic mechanisms. 
CRS is now recognized as various kinds of inflammatory diseases of the nasal and 
paranasal cavities 4. The differentiation of the inflammation types based on T helper 
cells or biomarkers allows a more differentiated classification. We can classify 
according to pathomechanical principles into so-called endotypes within the clinical 
phenotypes 5,6. Generally inflammation of CRSsNP is mostly Th1-skewed 
neutrophilic inflammation with elevated levels of interferon-γ (IFNγ) and 
transforming growth factor-β (TGFβ), whereas inflammation in CRSwNP is often 
Th2-skewed eosinophilic inflammation with elevated levels of IL5 and IgE 7. 
Patients with CRS also form a heterogeneous group with different endotypes, 
meaning that inflammation patterns and T helper subsets vary. A well-defined 
endotype of CRS disease can identify specific pathological or immunological 
characteristics of the inflammation. The inflammatory pattern can be related to the 
type of bacterial colonization. 
Association of microbes with CRS 
In chapter 6, we showed the association of mucosal organisms with 
patterns of inflammation in CRS. With the Uniprobe, we detected bacteria in healthy 
control tissues. The intramucosal presence of bacteria has been demonstrated not 
only using molecular methods, but also using culture techniques 8. Apparently, the 
sinus mucosa is not sterile and bacteria can colonize inside the tissue without 
132 
triggering inflammation. This finding supports the relationship between host and 
microbes in a healthy state. Although bacteria were detected in control tissues, the 
putative pathogens were significantly more present in diseased tissues than in 
control tissues. S. aureus was associated with IL-5 and SE-IgE positive sinonasal 
tissues of CRSwNP patients. A previous study showed that the presence of IL-5 and 
SE-IgE in sinonasal tissue is associated with comorbid asthma 9. Contrary to our 
expectations, intramucosal presence did not correlate with bacterial load on the 
mucosal surface. The abundance of S. aureus of CRSwNP with comorbid asthma 
group was similar to those of control group. S. aureus may behave in a commensal 
or pathogenic fashion based on strain, bacterial gene expression, environmental 
conditions, and possibly based on surrounding microbial interactions. We found 
variations of S. aureus strains according to the agr system between the healthy 
control group and CRSwNP group. The majority of S. aureus strains isolated from 
CRSwNP patients expressed agr group I and agr group II. According to our 
findings, S. aureus agr group I and group II strains are more virulent than S. aureus 
agr group III and group IV strains. The role of S. aureus in sinonasal inflammation 
has been shown to go beyond the traditional model of infectious inflammation. S. 
aureus can reside in sinonasal epithelium and release enterotoxins that may 
contribute to the Th-2 response in CRSwNP context. In CRSsNP disease, the 
mucosal presence of P. aeruginosa was significant in sinus tissue of CRSsNP 
patients with TNFα > 20 pg/mL. According to the visual analog score, CRSsNP 
patients who have TNFα > 20 pg/mL in their sinus tissue have remarkably more 
pain symptoms than CRSsNP patients who have TNFα < 20 pg/mL in their tissue. In 
addition, the sinus tissues with TNFα > 20 pg/mL coincide with an elevated level of 
IFNγ and IL-22. From these findings we can presume that P. aeruginosa contributes 
to the pathogenesis of Th1 and/or Th22 CRS disease. Elimination of P. aeruginosa 
possibly reduces the inflammation and pain symptoms in CRSsNP patient. We 
found variations of intramucosal bacteria among the different CRS endotypes. Our 
findings reveal that P. aeruginosa is associated with Th1 and/or Th22 CRS disease 
whereas S. aureus is associated with Th2-bias CRS disease. These findings indicate 
that bacteria probably have an impact on the type of CRS inflammation. 
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Disruptions of the Microbial Composition in CRSwNP. 
In chapter 7, the sinonasal microbiota of CRSwNP group showed 
significantly decreased bacterial diversity and evenness when compared with the 
healthy control group. These findings indicate the higher relative abundance of a 
few species in the bacterial community of in CRSwNP patients than those of healthy 
subjects. Further analysis revealed that Haemophilus influenzae was significantly 
more abundant in CRSwNP patients than in healthy control subjects. H. influenzae 
is the main causative infectious bacteria implicated in acute rhinosinusitis 10. H. 
influenzae produces toxins that interfere with ciliary function and that damage 
mucosal cells 11. In vitro experiments using human lung epithelial cell lines showed 
that H. influenzae penetrated into the subepithelial layer by passing between 
epithelial cells 12. H. influenzae can invade and survive in a variety of human 
epithelial cells and macrophages. Intracellular H. influenzae was detected in the 
adenoidal cells 13, bronchial epithelial cells 14, and macropharge cells 15. However, 
the intracellular colonization of H. influenzae in sinonasal epithelial cells is still 
unknown. Intracellular H. influenzae can avoid immune clearance mechanisms and 
cause a persistent infection. Persistent infection with H. influenzae can alter the 
adaptive immunity from Th1 to Th2 responses 16. In a murine model H. influenzae 
was shown to orchestrate the immune system to aggravate allergic airway disease by 
decreasing regulatory T cell (Treg)-associated fork head box P3 (FOXP3) gene 
expression in lung tissues and increasing secretion of inflammatory cytokines IL-5 
and IL-13 17. Interestingly, in humans, a deficit in Foxp3+Treg cells was shown to be 
a characteristic of CRSwNP disease 18. This evidence indicates that H. influenzae 
probably drives inflammatory responses in the development of nasal polyposis. 
Further investigation is needed to identify the role of H. influenzae in the 
pathogenesis of nasal polyposis. 
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Bacterial Communities and Impact on Inflammatory Pattern 
In a subset of CRSwNP patients, the abundance of S. aureus between non-
asthmatic patients and asthmatic patients did not reach the level of statistical 
significance. Furthermore, the S. aureus strain classified by agr group did not differ 
significantly between CRSwNP-A and CRSwNP+A groups. These findings indicate 
that other factors contribute to inflammatory patterns. CRSwNP patients with co-
morbid asthma normally have a high level of IgE, SE-IgE, and IL-5 in their 
sinonasal tissues 6. These biomarkers can be produced locally in the sinonasal 
mucosa, so resident microbes should contribute to the initiation and amplification of 
this reaction. Based on our finding, we can hypothesize that a Proteobacteria-rich 
condition probably aggravates type 2 inflammation in CRSwNP patients. Local 
microbes may induce mucosal inflammation under certain conditions. Local 
immunity may be regulated by either resident microbiota or microbial 
metabolites/components. Diseases that originate on mucosal membranes, like CRS 
diseases, might ensue from the action of polymicrobial communities of indigenous 
organisms, working in concert, resulting in the disruption of homeostatic 
mechanisms. 
Conclusions and Perspectives 
CRS is not a singular disease. Complex pathophysiology has been 
described in different CRS subgroups 6. Sinonasal mucosa is a complex and 
dynamic ecosystem, which is inhabited by many microorganisms. Mucosal 
immunity is entrusted with the formidable task of protecting the host from microbial 
invasion while maintaining a peaceful coexistence with its resident microbiota. 
Changes in the composition of the nasal microbiota potentially impact the complex 
pathophysiology of CRS disease. The inflammations of CRS disease do not ensue 
from individual bacterium, but probably are resulted from an entire microbial 
community under the influence of specific conditions. The functional part of a 
microbial community should be investigated to determine the role of microbiota in 
pathogenesis of CRS disease. The function of bacterial communities probably forms 
the pattern that maintains physiological processes or initiates detrimental 
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inflammation of the host. The host-microbe interaction studies have involved 
introducing infection by individual organisms (and evaluating subsequent 
inflammatory responses), rather than infection by a collection of organisms 
simultaneously, which could conceivably yield different findings. In the future 
researchers should consider a model of studying human-microbe interaction by 
infecting with series of microbes. The role of nonbacterial microbiota (fungi, 
viruses) still remains to be investigated for their contribution to CRS pathogenesis. 
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Summary 
Chronic rhinosinusitis (CRS) is a common disease that is characterized by 
prolonged mucosal inflammation of the nose and paranasal sinuses. CRS can be 
classified into two clinical subgroups based on the absence or presence of nasal 
polyps (CRS without (sine) nasal polyps, CRSsNP; or CRS with nasal polyps, 
CRSwNP). This classification suggests an individual therapeutic approach for 
patients. However, these broad phenotypes do not provide full insight into the 
potential underlying cellular and molecular mechanisms of CRS. Recognition of the 
heterogeneity of CRS has promoted the concept that CRS consists of multiple 
groups of biological subtypes (endotypes) that are defined by distinct 
pathophysiologic mechanisms. Multiple host and environmental factors have been 
implicated in the development of CRS; now more importance is placed on the role 
of microbes. The simple concept of a host interacting with a single pathogen has 
been replaced by a more complex combination of relationships between microbial 
communities and the host. 
This study assesses the association between the upper airway microbiota 
and the severity of chronic rhinosinusitis. It is hypothesized that infectious processes 
are associated with inflammatory patterns. The most likely infectious agents in the 
context of persistent inflammation of sinonasal mucosa are bacteria. Previous 
research indicated that IL-5 positive nasal polyps are associated with Gram-positive 
bacterial colonization. Staphylococcus aureus significantly increases in a subgroup 
of chronic rhinosinusitis with nasal polyps, however various other microbes may 
play a role either in the progression or the regression of sinonasal disease. We 
employed peptide nucleic acid fluorescence in situ hybridization (PNA-FISH) to 
detect intramucosal sinonasal tissue microorganisms. We furthermore used high 
throughput sequencing to detect the bacterial 16S ribosomal ribonucleic acids 
(rRNA) gene on the nasal mucosal surface. Relevant proteins were measured in 
sinonasal tissues to define the endotypes of CRS using ELISA, Luminex, and 
UniCAP systems. 
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Our findings suggest that intra-mucosal S. aureus is associated with Th2-
bias CRSwNP tissues and sinonasal tissues from cystic fibrosis disease. In addition, 
sinonasal tissues of CRSsNP patients with TNFα > 20 pg/ml are associated with the 
intra-mucosal presence of Pseudomonas aeruginosa. Fungi are rarely detected in 
intra-mucosal tissue using the pan fungal probe, so it seems they do not play a major 
role in pathogenesis of CRS. 
We found variations of bacteria on the surface of nasal mucosa in 
CRSwNP patients characterized by co-morbid asthma. Haemophilus influenzae was 
significantly enriched in CRSwNP patients when compared to healthy control 
subjects. The most dominant microbe was Propionibacterium acnes in healthy 
control subjects, S. aureus in CRSwNP patients without asthma and Escherichia coli 
in asthmatic CRSwNP patients. Furthermore, the most abundant bacterial species in 
the healthy state (i.e. P. acnes) could not inhibit survival or growth of the relevant 
bacterial species in CRS disease state (i.e. H. influenzae, E. coli and S. aureus). The 
levels of propionic acid measured in the sinonasal environment did not reach the 
minimum inhibitory concentration for a putative pathogen (i.e. S. aureus). These 
findings prompt us to further investigate the role of bacterial communities and 
products in pathophysiologic processes of chronic rhinosinusitis. We conclude that 
dysbacteriosis of the nasal mucosa is linked to inflammatory patterns in chronic 
rhinosinusitis. 
Future research should use integrated approaches to link microbial structure 
and activity. Non-bacterial microbes (i.e. fungi and viruses) may also contribute to 
the community of interacting biological entities. The composition and function of 
the microbiota possibly play a significant role in disease pathophysiology. The 
interaction of microbes with mucosal immune responses and interspecies 
interactions within the sinonasal community warrants further investigation. 
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Samenvatting 
Chronische rhinosinusitis (CRS) is een veelvoorkomende ziekte die 
gekenmerkt wordt door een langdurige ontsteking van het neusslijmvlies en de 
neusbijholten. CRS wordt ingedeeld in twee klinische subgroepen op basis van de 
af- of aanwezigheid van neuspoliepen (CRSsNP, CRS zonder (sine) neuspoliepen of 
CRSwNP, CRS met neuspoliepen). Deze classificatie suggereert een 
geïndividualiseerde behandeling van patiënten. Deze brede fenotypes bieden echter 
geen volledig inzicht in de mogelijke onderliggende cellulaire en moleculaire 
mechanismen van CRS. Erkenning van de heterogeniteit van CRS heeft het concept 
gepromoot dat CRS uit verschillende biologische subtypes (endotypes) bestaat, die 
worden gedefinieerd door verschillende pathofysiologische mechanismen. Meerdere 
gastheer- en omgevingsfactoren hebben een rol gespeeld bij de ontwikkeling van 
CRS; nu wordt er meer belang gehecht aan de rol van microben. Het eenvoudige 
concept van een gastheer die interactie heeft met één pathogeen is vervangen door 
een complexere combinatie van relaties tussen microbiële gemeenschappen en de 
gastheer. 
Deze studie evalueert de associatie tussen de microbiota in de bovenste 
luchtwegen en de ernst van chronische rhinosinusitis. Men veronderstelt dat 
infectieuze processen geassocieerd zijn met ontstekingspatronen. De meest 
waarschijnlijke infectieuze agentia in de context van aanhoudende ontsteking van 
het sinonasaal slijmvlies zijn bacteriën. Eerder onderzoek wees uit dat IL-5 positieve 
neuspoliepen geassocieerd zijn met grampositieve bacteriële kolonisatie. 
Staphylococcus aureus neemt significant toe in een subgroep van chronische 
rhinosinusitis met neuspoliepen, maar verschillende andere microben kunnen ook 
een rol spelen bij de progressie of de regressie van rhinosinusitis. We gebruikten 
peptide nucleïnezuur fluorescentie in situ hybridisatie (PNA-FISH) om 
intramucosale sinonasale weefselmicro-organismen te detecteren. Verder gebruikten 
we “high-throughput sequencing” om de genen van de bacteriële 16S-ribosomale 
ribonucleïnezuren (rRNA) op het neusslijmvliesoppervlak te detecteren. Om de 
endotypes van CRS te definiëren, werden relevante eiwitten gemeten in sinonasale 
weefsels met behulp van ELISA, Luminex en het UniCAP systeem. 
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Onze bevindingen suggereren dat intra-mucosale S. aureus wordt 
geassocieerd met CRSwNP weefsels met een Th2-respons en met sinonasale 
weefsels van cystische fibrose. Bovendien zijn sinonasale weefsels van CRSsNP 
patiënten met TNFα > 20 pg/ml geassocieerd met de intra-mucosale aanwezigheid 
van Pseudomonas aeruginosa. Schimmels werden zelden gedetecteerd in intra-
mucosaal weefsel met behulp van de “pan fungal probe”. Het lijkt er dus op dat ze 
geen belangrijke rol spelen in de pathogenese van CRS.  
 Bij CRSwNP patiënten met asthmacomorbiditeit vonden we verschillende 
bacteriën op het oppervlak van het neusslijmvlies. Haemophilus influenzae was 
significant verrijkt bij CRSwNP patiënten in vergelijking met gezonde 
controlepersonen. De meest dominante microbe was Propionibacterium acnes bij 
gezonde controlepersonen, S. aureus bij CRSwNP patiënten zonder astma en 
Escherichia coli bij astmatische CRSwNP patiënten. Bovendien kon de meest 
overheersende bacteriesoort in de gezonde toestand (i.e. P. acnes) de overleving of 
groei van de relevante bacteriesoorten in de CRS toestand (i.e. H. influenzae, E. coli 
en S. aureus) niet inhiberen. De hoeveelheden propionzuur gemeten in de sinonasale 
omgeving bereikten niet de minimale inhiberende concentratie voor een vermeend 
pathogeen (i.e. S. aureus). Deze bevindingen sporen ons aan om de rol van 
bacteriële gemeenschappen en hun producten in pathofysiologische processen van 
chronische rhinosinusitis verder te onderzoeken. We concluderen dat dysbacteriose 
van het neusslijmvlies gekoppeld is aan ontstekingspatronen bij chronische 
rhinosinusitis. 
Toekomstig onderzoek zou geïntegreerde benaderingen moeten 
gebruiken om de microbiële structuur en activiteit te koppelen. Niet-bacteriële 
microben (bv. schimmels en virussen) kunnen ook bijdragen aan de gemeenschap 
van interagerende biologische entiteiten. De samenstelling en functie van de 
microbiota spelen mogelijk een belangrijke rol in de ziektepathofysiologie. De 
interactie van microben met mucosale immuunreacties en interacties tussen species 
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